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ABSTRACT 
 
JENNIFER NICHOLS: Genetic and genomic mechanisms of neonatal hyperoxic lung 
injury in the inbred mouse  
(Under the direction of Dr. Steven Kleeberger) 
 
 Oxidative stress contributes to the pathogenesis of many respiratory disorders, 
including bronchopulmonary dysplasia (BPD), or chronic lung disease in infants. 
Treatment of BPD often involves respiratory support with high oxygen levels, and 
oxidant injury is an adverse side effect associated with vascular damage and impaired 
lung development and function in a subset of infants. Differential susceptibility to BPD is 
poorly understood and previous studies have demonstrated genetic susceptibility to 
hyperoxic lung injury in strains of adult inbred mice. Furthermore, genetic 
polymorphisms in a few candidate genes have been associated with BPD in clinical 
cohorts; however, specific genetic factors predisposing neonates to oxidant lung injury 
are poorly understood. The objective of this dissertation was to utilize integrated genetic 
and genomic approaches to identify predictors of susceptibility to neonatal hyperoxic 
lung injury. Neonates from 36 strains of inbred mice were screened for lung injury 
phenotypes in response to 72 hours of 100% oxygen exposure. Phenotypes exhibited 
heritability and haplotype association mapping identified quantitative trait loci (QTLs) 
for bronchoalveolar lavage macrophage and neutrophil counts. Underlying candidate 
susceptibility genes included Chrm2, Mgmt, and Cyp2j6. Further investigation of Chrm2 
by targeted gene deletion confirmed a functional role of Chrm2 and its encoded M2 
muscarinic acetylcholine receptor as gene deletion resulted in significantly diminished 
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alveolar hyperpermeability and pathology. Expression QTL (eQTL) and gene expression-
phenotype correlation analyses revealed genomic variation in normal postnatal lung 
development and in response to hyperoxia in inbred neonates. There were 29 cis-eQTLs 
identified at baseline, and candidate genes included Adam17, Tnfaip2, and Eif2ak2. There 
were 23 hyperoxia-responsive cis-eQTLs, and Trim30, Casp9, and Vcp were candidate 
genes of biological interest. Further integration of genetic and genomic analyses included 
gene ontology and pathway analysis, which implicated canonical pathways including 
mitogen-activated protein kinase and NFκB signaling. Ultimately, novel candidate 
susceptibility genes were discovered that underlie susceptibility to hyperoxic lung injury 
and may improve identification of the susceptible neonatal population at risk for 
developing BPD and provide targets for therapeutic intervention.  
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CHAPTER 1 
 
INTRODUCTION 
 
Bronchopulmonary dysplasia: Epidemiology and significance 
Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease that is 
associated with premature birth and low birth weight (Kinsella, 2006 #150). Although it 
is just one of the many challenges these babies face, it is one that has not subsided with 
the vast improvements in neonatology over the past decades. From 1980 to 2008, the 
frequency of prematurity, or babies born before 37 weeks gestational age (GA), increased 
from 8.9% to 12.8%. Similarly, low birth weight (LBW, less than 2500 grams or 5 
pounds and 8 ounces) increased from 6.8% to 8.2% (1, 2). The rise in survival rates of 
very low birth weight (VLBW, less than 1500 grams or 3 pounds 4 ounces) from 1960 to 
2000: 45% to 93% (2, 3) is remarkable. Also noteworthy is the survival of over half of 
infants born at 24 weeks GA (4). Despite these advances, a recent study conducted the 
National Institute for Child Health and Development reported that 68% of babies born 
before 28 weeks GA are diagnosed with BPD with a survival rate at discharge of 43% 
(5). Overall, preterm and LBW infants fare far better than in previous decades but are still 
challenged by many morbidities, the greatest of which is BPD (6).  
Preterm infants experience respiratory difficulties such as BPD due to an 
underdeveloped pulmonary system. The lungs are the last organ to develop in the human 
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fetus, and their full maturation is not realized until after birth (7). Premature babies often 
require respiratory support including mechanical ventilation and/or supplemental oxygen 
in order to achieve adequate oxygenation (8, 9), and respiratory difficulty is 
proportionally related to gestational age. In the United States, there are approximately 
14000 new cases annually (10, 11), and while this is not among the most common 
diseases, it presents a substantial burden to the health care system for a variety of reasons.  
Beyond the extensive medical care required at birth, as many as 60% of children 
diagnosed with BPD require re-hospitalization through early childhood than children not 
diagnosed with BPD (12-15). Furthermore, these children have poor performance in 
pulmonary function tests in childhood and beyond, including reduced forced expired 
volume (FEV1) and forced vital capacity (FVC) (14, 16-18). Asthma incidence and the 
use of bronchodilators and inhaled steroids are increased among these children (19), and 
neurological development is also adversely affected and cerebral palsy, neurosensory and 
motor abnormalities as well as impaired cognitive abilities have been described 
throughout childhood (20-26). All of these challenges significantly impact the daily lives 
of the families affected and reduce the overall quality of life for these children (27). 
 
Bronchopulmonary dysplasia: Etiology 
BPD was first described by Dr. William H. Northway, Jr. (28). He reported a new 
type of chronic lung disease, including clinical, radiographic, and histologic changes in 
lungs, in moderately preterm infants diagnosed with respiratory distress syndrome (RDS) 
and treated with supplemental oxygen and mechanical ventilation (28). Historically, if 
infants with RDS survived beyond the first 3 days of life, full recovery and normal lung 
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development was to be expected; however, Northway observed that a subset of infants 
survived RDS with persistent lung damage (28, 29). Initially, 4 stages of BPD were 
described beginning with RDS, followed by bronchiolar and alveolar epithelial necrosis 
that led to alveolar atelectasis and pulmonary fibrosis. The final stage, after 1 month of 
age, resulted in postnatal lungs with several abnormal pathologies, including airway 
epithelial lesions, irregular regions of atelectasis and hyperinflation, decreased alveolar 
surface area, airway smooth muscle hyperplasia, fibroproliferation, vascular lesions, and 
oxidative stress (29-31). These infants required respiratory support, which was limited to 
mechanical ventilation and supplemental oxygen in the past.  
Over time, there has been an evolution of BPD from this original description to 
what is observed in the clinic today as a result of advances in medical treatment and 
technology. The use of antenatal steroids, synthetic surfactant, milder ventilation 
strategies, and oxygen monitoring has significantly contributed to the marked increase in 
survival of very preterm infants. Furthermore, these clinical care improvements have 
minimized chronic lung disease in moderately preterm infants (32, 33). At approximately 
25 weeks of gestation, lungs begin saccular development at which point sacculi separated 
by primary septa containing capillary networks emerge (Figure 1.1, 1.2B). Surfactant 
synthesis also begins, which gives rise to a prenatal lung that is adequately capable of 
respiration with minimal medical intervention. Prior to this stage, cannalicular 
development, or formation of the respiratory portion of the lung, is ongoing as acini begin 
to form from the terminal bronchiole and capillaries extend into the mesenchyme (Figure 
1.2A). The extracellular matrix begins to degrade and type I pneumocytes differentiate 
from the type II pneumocytes (34). These very preterm lungs require more invasive 
4 
 
medical support. Thus, BPD in its new form is a developmental disorder characterized by 
impaired alveolar development and irregular pulmonary vascularization with variation in 
fibrosis and inflammation (6, 35).  
This disease evolution is largely the result of identification of risk factors 
contributing to BPD, which in addition to the degree of prematurity include mechanical 
ventilation, supplemental oxygen, genetics, and pre and postnatal disorders and infections 
(30, 31, 36, 37). Patent ductus arteriosus (PDA), or failed closure of the vasculature 
connecting the pulmonary artery and aortic arch, is a pathophysiological disorder 
associated with BPD. PDA causes irregular blood flow between the heart and lungs, 
which creates greater lung pressure and makes respiration more difficult (38). PDA in 
preterm infants, often in combination with infection or sepsis, significantly increases the 
risk of BPD (31, 39). 
Infection, either postnatal or in utero, has been inconsistently associated with 
development of BPD but is generally accepted as a risk factor as it initiates inflammation 
that interferes with normal development (31, 40, 41). Clinical studies have revealed that 
chorioamnionitis is linked to respiratory tract infections after birth, and that in cases of 
prematurity, a majority of infants develop BPD (36, 42). Similarly, postnatal infections 
related to BPD include cytomegalovirus, ureaplasma, and mycoplasma (43-46). 
Preterm infants at the threshold of viability will be exposed to some combination 
of ventilation and oxygen therapy; however, these life-saving interventions are also risk 
factors. Ventilator-induced lung injury can result from application high tidal volume, 
high peak airway pressure, and insufficient positive and expiratory pressures (9, 41, 47). 
Overdistention of the small airways and alveolar permeability have been described in 
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clinical and animal studies that give rise to permanent structural damage in the 
developing lung and contribute to BPD. Recent years, though, have seen great 
improvements in ventilation strategies including application of continuous positive 
airway pressure. Careful monitoring of tidal volume and pressure has reduced, but not 
eliminated, ventilator-induced lung injury and BPD in neonates (9, 41).  
Administration of supplemental oxygen has long been the standard of care in 
treating preterm infants and is a requirement for diagnosis of mild, moderate and severe 
BPD (31, 48). Inefficient gas exchange of the immature lung results in inadequate body 
oxygenation. To reduce mortality, supplementation with oxygen through ventilation 
began in the 1930s (48), and while this therapy has been largely successful, it has 
associated risks. If the oxygen levels in the preterm infant are not carefully monitored, 
disorders including cerebral palsy and retinopathy of prematurity can result. However, 
even with careful observation in oxygen administration, preterm infants are still at risk 
for developing BPD because it is not possible to accurately determine if there is an 
oxidant imbalance in the developing lung (41). An appropriate balance of pro-oxidant-
antioxidant balance is imperative in biological processes and supplemental oxygen in the 
neonatal lung favors pro-oxidants, inducing a state of oxidative stress as it has reduced 
antioxidant defenses. Furthermore, infections and inflammation can exacerbate oxidative 
stress by activating production of reactive oxygen species (ROS) in an iron rich 
environment (49, 50). Though there are many factors contributing to the development of 
BPD, evidence from clinical and animal studies demonstrate that oxygen therapy and 
oxidative stress play an important role (51, 52).  
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Neonatal hyperoxic lung injury 
The role of oxidative stress in BPD is not fully understood and research has 
focused on determining why disease prevalence has not subsided with improved 
treatment strategies including saturated oxygen monitoring, alternate respiratory support, 
and surfactant therapy. Oxygen toxicity is involved in the pathogenesis of many diseases 
in addition to BPD such as carcinogenesis, neurodegenerative disorders, diabetes, 
atherosclerosis, chronic inflammatory diseases, and aging (53-57). Furthermore, adult 
respiratory disorders (e.g. respiratory distress syndrome, emphysema) that require oxygen 
therapy are also thought to be burdened and exacerbated by oxidative stress (58). While 
important in all systems, oxidant balance is of particular interest in the lungs because it is 
a delicate interface with a harsh environment.  
Oxidative stress is the result of pro-oxidant antioxidant imbalance. A biological 
system can become stressed when there is more oxygen present than it can efficiently 
consume through mitochondrial respiration. Consequently, there is an inappropriate 
release of the intermediates of respiration, which are strong ROS. Given the high 
electronegativity of oxygen, these radicals can easily modify macromolecules such as 
proteins, DNA, and lipids by extracting electrons from unsaturated carbon atoms and 
sulfhydryl groups. The modified products have dramatically different effects as protein 
oxidation can modulate enzyme activity and signal transduction, lipid peroxidation can 
lead to membrane permeability and apoptosis, and oxidized DNA can cause abnormal 
cell cycle regulation (59-64). Thus, ROS significantly alter “normal” biochemical 
processes. 
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Defense mechanisms exist at the extracellular and intracellular level to counteract 
ROS. Extracellular defenses mostly consist of scavengers that are readily oxidized by 
ROS and include vitamin C, uric acid, and bilirubin. Enzymatic defense mechanisms are 
predominantly localized within cells and include superoxide dismutase (SOD), catalase, 
and glutathione peroxidase. These enzymes are able to convert ROS to less reactive 
chemical moieties. For example, glutathione peroxidase and catalase efficiently 
metabolize hydrogen peroxide to yield water and oxygen. Furthermore, these enzymes 
are rapidly inducible upon ROS insult, which has been demonstrated in in vivo and in 
vitro studies of hyperoxia (65, 66). 
Understanding the complexities of oxidative stress has enabled researchers to 
better describe the underlying role it may have in BPD. Studies in preterm infants have 
demonstrated that there is positive correlation between development of BPD and markers 
of lipid peroxidation, including exhaled pentane and ethane and increased 
malondialdehyde levels in plasma, urine, and bronchoalveolar lavage fluid (67-70). 
Moreover, protein oxidation as measured by carbonyl concentration is elevated in 
tracheal aspirates in preterm infants requiring 40% oxygen and ventilation compared to 
preterm infants requiring less invasive support (71, 72). Animal models of neonatal 
hyperoxic lung injury support these clinical findings as lipid peroxidation and protein 
oxidation products are increased following hyperoxia exposure (73-75).  
The preterm neonatal lung is further challenged because it has significantly 
reduced antioxidant capabilities. Beyond exposure to high oxygen levels and surfactant 
deficiency, antioxidant enzymes have marginal expression and are inefficient in preterm 
lungs (76). Frank and Groseclose (77)conducted a hallmark study in fetal rabbits that 
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showed antioxidant enzymes to increase by 150% during the last 15% of gestation. 
Similarly, lipid peroxidation decreases with gestation age in human placental and fetal 
tissues, suggesting that antioxidant enzyme activity increases through gestation (78). It 
has also been suggested that there is only marginal induction of antioxidant enzymes 
following oxidative stress in preterm lungs. As a result of insufficient antioxidant 
defenses, the preterm lung is predisposed to oxidative stress leading to inflammation 
(neutrophil influx and edema), impaired development, and abnormal vasculogenesis.  
 
Genetic susceptibility to Bronchopulmonary Dysplasia 
Support for a genetic contribution to BPD susceptibility evolved as variation in 
frequency and severity of BPD in preterm infants having similar environmental risk 
factors was identified (79). Initial evidence for susceptibility to BPD was described by 
disparate patterns of disease frequency and severity in race and gender as Caucasian male 
preterm infants had increased disease frequency compared to African American and 
female preterm infants (80). A twin study indicated increased risk for BPD in twin pairs 
independent of a variety of other factors such as gestational age and gender (81). Another 
twin study reported that genetics accounted for 79-82% variation in BPD and Bhandari et 
al. calculated a heritability of 53% after controlling for covariates (82, 83). Preterm 
infants are also at greater risk for developing BPD in cases with maternal diabetes, birth 
asphyxia, and familial asthma (37, 84 ).  
Polymorphisms in many genes involved in lung development, vasculogenesis, 
innate immunity and inflammation, and antioxidant defense have been considered in 
BPD, including surfactant protein A (SFTPA), surfactant protein B (SFTPB), vascular 
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endothelial growth factor (VEGF), interleukin-1β (IL1B), interleukin-10 (IL10), 
transforming growth factor β (TGFβ),  insulin-like growth factor (IGF), monocyte 
chemotactic protein-1 (CCL2), angiotensin converting enzyme (ACE), glutathione s-
transferase (GSTF), and tumor necrosis factor α (TNFA) (31, 37, 85, 86). However, 
associations between candidate gene polymorphisms and risk of BPD have been 
inconsistent across studies. Association studies assume that a single nucleotide 
polymorphism (SNP) in the genome will significantly associate with a disease marker or 
phenotype and require an adequate sample size to have sufficient power (85), which is 
rarely the case in studies of BPD. Furthermore, though SNPs are common (compared to 
rare alleles), they typically have modest effects of disease and/or phenotype. Taken 
together, GWAS in human cohorts of BPD face significant challenges that will be 
difficult to circumvent.  
Animal studies have also supported a role for genetic susceptibility in hyperoxic 
lung injury. For example, Cho et al. (87) found significant inter-strain variation in 
inflammatory and injury responses to hyperoxia in adult mice, and linkage analysis 
studies identified candidate genes including Nrf2. Similarly, Prow et al. (88) found 
variation in survival time across inbred strains of adult mice exposed to hyperoxia and 
Whitehead et al. (89) described differences in hyperoxia-induced inflammation, 
extracellular matrix remodeling, and antioxidant defense. Currently, there are no 
published studies describing variation in animal models of neonatal hyperoxic lung 
injury. 
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Application of a genetic model 
Despite advancements in understanding BPD, there has been little impact in 
improving outcomes. Reported studies demonstrate a genetic association; however, genes 
that have been primary suspects in disease do not consistently correlate to disease 
frequency or severity. Furthermore, efforts to understand the susceptible population have 
been unsuccessful as there are not currently any known predictors of response or 
protection. Previous human association studies have been limited by small samples and 
confounding variables. Identification of susceptibility genes is further complicated in 
these populations because BPD is likely a polygenic disease, and the effects of a single 
gene in a small sample may account for only a small proportion of the genetic variance. 
Studies that investigated the pathogenesis of BPD in large mammalian models such as the 
baboon have proved useful; however, use of these animals for genetic studies is limited 
by small sample size and outbreeding. The present study has employed a neonatal inbred 
murine model of hyperoxic lung injury that bypasses some of the difficulties present in 
human and primate studies.  
A NHLBI/NICHD Workshop on Bronchopulmonary Dysplasia (90) identified 
research initiatives to improve characterization and treatment of BPD, including 
identification of genetic contributors to BPD in human populations. The report suggested 
that development of mouse models would enable manipulation and functional analysis of 
specific candidate genes (90).  
The objective of this dissertation was to utilize an integrated genetics and 
genomics approach to identify predictors of susceptibility to BPD in preterm infants 
using a neonatal murine model of hyperoxic lung injury (Figure 1.3). This model of 
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neonatal hyperoxic lung injury was employed in 36 strains of inbred mice, and 
hyperoxia-induced lung injury phenotypes were used in haplotype association mapping to 
identify quantitative trait loci (QTLs) and candidate susceptibility genes. Furthermore, 
differential gene expression in lungs from 30 strains of inbred mice at baseline (postnatal 
day 4) and after hyperoxia exposure was described and used for expression QTL (eQTL) 
analysis. Baseline and hyperoxia-induced gene expression in the lung were also evaluated 
for correlation to hyperoxic lung phenotypes. Overall, genetic determinants that underlie 
predisposition or susceptibility to neonatal oxidant lung injury and variation in hyperoxia 
response mechanisms were described, and hypotheses were generated for validation in 
human disease cohorts of BPD.  
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Figure 1. 1 Schematic of embryonic and fetal lung development. Stages of lung 
development from embryogenesis to birth are described for the human respiratory 
system. Reprinted with permission from Elsevier. Pharmacology &  Therapeutics 114 , 
2007(91). 
 
 
 
 
 
 
 
 
 
 
 
13 
 
Figure 1. 2 Lung tissue sections from preterm infants. A. A lung tissue section from a 
24 week gestational age infant is shown and depicts cannalicular development. A 
terminal bronchiole (b) is present, but respiratory bronchioles and alveoli are not. B. A 
lung tissue section from a 32 week gestation age infant. Saccular development is shown 
by the presence of saccule spaces and secondary crests. Reprinted with permission from 
Elsevier, Seminars in Neonatology 8(1), 2002 (92). 
 
  A.              
             
B.  
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Figure 1. 3 Schematic of dissertation objective. Haplotype association mapping with 
hyperoxic lung injury phenotypes, expression QTL analysis, and global gene expression 
analysis will be used to identify candidate susceptibility genes. Candidate susceptibility 
genes will then be prioritized and tested in a disease model.  
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
 
A MURINE MODEL OF HYPEROXIA-INDUCED LUNG INJURY IN INBRED 
NEONATE MICE 
 
Introduction 
Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease that is 
associated with prematurity and an underdeveloped pulmonary system. The lung is a 
unique organ because maturation is not realized until after birth, and babies born 
prematurely (before 36 weeks post-menstrual age) are often incapable of adequate 
respiration. To compensate, surfactant therapy, mechanical ventilation and supplemental 
oxygen are often utilized until respiration can be maintained independently. While this 
treatment strategy has been largely successful, a subset of preterm infants remains that is 
adversely affected, the reasons for which are poorly understood. These babies experience 
an arrest in lung development which includes impaired alveolarization and abnormal 
vascularization, and decreased respiratory function has been reported beyond childhood.  
Initial efforts to understand differential susceptibility to BPD have revealed a 
strong genetic component. Studies conducted in mono- and dizygotic twins reported 
heritability estimates ranging from 53% to 82% (82, 83). Studies beyond heritability 
estimates have investigated associations between disease development and severity and 
genetic variants in pathological processes underlying BPD including inflammation, 
antioxidant defense, lung development, and vascular development (6, 35, 93, 94). 
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Unfortunately, most of these associations have not been replicated due to small sample 
sizes and confounding variables. 
Animal models of human disease have been developed for a variety of human 
diseases with much success in circumventing challenges presented in human clinical 
studies. The mouse has been the most commonly applied model system used to study 
human disease because of the high degree of conservation in genetics and physiology. 
Furthermore, disease models have proved to be advantageous because exposures can be 
tightly controlled, invasive phenotypes can be measured, and a multitude of resources for 
validation are available (95). It has been suggested in the recent decade that appropriate 
animal models are needed to better understand key events in lung development during the 
transition from saccularization to alveolarization and factors contributing to BPD. 
Additionally, appropriate animal models will be crucial to validate pathogenic events and 
proposed treatment strategies (90).  
The overall objective of Chapter 2 is to describe a neonatal murine model of 
hyperoxic lung injury with phenotypes that are characteristic of BPD. A phenotype 
screen of this exposure model in neonatal mice from 36 inbred strains was done to 
identify strain-specific hyperoxic lung injury for haplotype association mapping (HAM). 
The hyperoxia-induced injury phenotypes from the strain screen were then used for in 
silico HAM analyses to identify quantitative trait loci (QTLs) that associate with 
susceptibility neonatal hyperoxic lung injury (Chapter 3). Together, results presented in 
chapters 2 and 3 demonstrate the utility of the mouse model for determining genetic 
factors that contribute to neonatal hyperoxic lung injury. 
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Methods 
Animals and hyperoxia exposure 
Thirty-six inbred strains of mice (The Jackson Laboratory, Bar Harbor, ME; 4-10 
weeks) were selected to maximize genetic diversity (Figure 2.1). Mice were caged 
individually, maintained in a 12:12 light:dark cycle at 72°F with 50% humidity, and 
provided food and water ad libitum. Mice acclimated to these conditions for at least a 
week prior to mating. Males and females were then housed together for 3-5 days and, 
following cohabitation, males were removed and 1-3 females were housed per cage until 
pregnancy was confirmed. At 12-24 hours after spontaneous birth, male and female pups 
were pooled and randomly assigned to exposure groups. Litters from all strains were 
cross-fostered with Swiss Webster dams (Charles River, Wilmington, MA) to ensure 
adequate and consistent maternal care. Litters with foster dams were maintained either in 
room air or a chamber supplied with ≥ 95% oxygen (UHP grade, min. purity 99.994%, 
National Welders, Durham, NC) for 72 hours. The chamber was opened for 
approximately 30 min each morning for health checks and cage cleaning. Foster dams 
were also replaced at this time to avoid changes in maternal care due to hyperoxia effects 
to the dam. After termination of exposure, mice were weighed and anesthetized by i.p. 
injection of sodium pentobarbital (104 mg/kg) (Figure 2.2). All animal use was approved 
by the NIEHS Animal Care and Use Committee.  
 
Bronchoalveolar lavage 
After anesthetization, the trachea was cannulated in situ, and the whole lung was 
lavaged four consecutive times with 100 µl Hank’s balanced salt solution (HBSS) (n ≥ 
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5/group). Bronchoalveolar lavage fluid (BALF) was kept on ice during necropsy and then 
centrifuged (500xg at 4°C, 10 min). The supernatant was removed and assayed for 
protein concentration using the Bradford method according to the manufacturer’s 
protocol (Bio-Rad, Hercules, CA). The cellular pellet was resuspended in 500 µl ice cold 
HBSS with 5% BSA, and total cell counts were obtained with a hemocytometer. 
Cytospins were prepared using 200-300 µl of the cell suspension and stained with 
Wright-Giemsa stain (Fisher Scientific, Pittsburgh, PA). Differential cell counts for 
macrophages, epithelial cells, and neutrophils were performed by identifying 300 cells 
according to standard cytological techniques.  
 
Lung histopathology 
After anesthetization, the whole lung was fully inflated intratracheally in situ with 
zinc formalin (Fisher Scientific, Pittsburgh, PA). The trachea was clamped and the lung 
removed and immersed in zinc formalin for 48 hours. Fixed lungs were then placed in 
70% ethanol until embedded, sectioned, and stained (hematoxylin and eosin) for 
pathological assessment.  
 
Affymetrix GeneChip analysis 
Gene expression analysis was done in whole lung homogenates from two 
hyperoxia resistant (BALB/cByJ and 129/SvImJ) and two hyperoxia susceptible 
(C57BL/6J and C3H/HeJ) inbred strains. Whole lungs were collected from 3 mice of 
each strain on postnatal day 4 and after 72 hours of 100% oxygen exposure and snap 
frozen in liquid nitrogen. RNA was extracted from approximately 20 mg of frozen lung 
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tissue using the RNeasy Plus Kit, the Tissuelyser LT, and the QIAcube according to the 
manufacturer’s protocol (Qiagen, Valencia, CA). RNA quality was verified (A260/A280 
> 1.8) and provided to the NIEHS Microarray Core (NMC).  
The NMC carried out the hybridization procedures using the Affymetrix Mouse 
Genome 430 2.0 platform (Affymetrix, Santa Clara, CA). 500 ng of total RNA was 
amplified using the Affymetrix 3’ IVT Express Kit protocol, running the biotin synthesis 
for 4 hours. 12.5 µg of amplified biotin-aRNAs were fragmented and 10 µg were 
hybridized to each array for 16 hours at 45°C in a rotating hybridization oven using the 
Affymetrix Eukaryotic Target Hybridization controls and protocol. Array slides were 
stained with streptavidin/phycoerythrin using a double-antibody staining procedure and 
then washed for antibody amplification according to the GeneChip Hybridization, Wash 
and Stain Kit manual. Arrays were scanned in an Affymetrix Scanner 3000 and data were 
obtained using the GeneChip Command Console Software (AGCC; Version 1.1) using 
the MAS5 algorithm to generate .CHP files. Data preprocessing, normalization, and error 
modeling was performed with the Rosetta Resolver System (Version 7.2, Rosetta 
Biosoftware, Seattle, WA) 
The hybridization intensity values were obtained from the MCF and 
transcriptomic analysis was completed using GeneSpring GX11.0.1 (Agilent 
Technologies, Santa Clara, CA). Genes were filtered for significance (p < 0.05) using a 
two-way ANOVA (strain, exposure) followed by Benjamini-Hochberg False Discovery 
Rate test for multiple comparisons.  K-means clustering analysis was then performed and 
clusters were selected that contained genes differentially expressed between air and 
hyperoxia lung tissue across strains. The genes contained in these clusters were then 
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evaluated for physiological function and gene network association using Ingenuity 
Pathway Analysis (IPA) (Ingenuity Systems, Redwood City, CA).  
 
Statistics 
Two-way analysis of variance (ANOVA) was used to evaluate the effects of 
exposure (air, hyperoxia) and strain on disease phenotypes. Student-Newman-Keuls test 
was used for a posteriori comparisons of means. Statistical significance was accepted at 
p<0.05. Correlation of phenotypes among the 36 strains was determined using Pearson’s 
correlation coefficients (Gene Network, University of Tennessee; 
www.genenetwork.org).  
 Heritability estimates were calculated for all phenotypes to determine the genetic 
proportion of total variation according to the following formula:  
 r1 = (MSB – MSW) / [MSB + (n – 1)MSW], 
where r1 is the intraclass correlation estimate, MSB is the mean square of the between-
strain variation, MSW is the mean square of the within-strain variation, and n is the 
number of animals used for each strain (96) 
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Results 
Variation in hyperoxic lung injury across strains of neonatal mice 
BALF was analyzed to determine protein concentration and differential cell 
populations as hyperoxic lung injury phenotypes. Significant inter-strain variation was 
found for hyperoxia-induced differences in the mean number of BALF total cells relative 
to air-exposed controls. Compared to air controls significantly more total cells were 
found following hyperoxia in a subset of strains (C3H/HeJ, FVB/NJ, SWR/J), whereas 
hyperoxia caused no change or fewer total BALF cells were found in other strains 
(BALB/cByJ, BALB/cJ, NZO/HILtJ; Table 2.1). Heritability of this phenotype across the 
36 strains was 47.6% (Table 2.2). 
Similar to BALF total cells, BALF macrophages, epithelial cells, and 
polymorphonuclear leukocytes (PMNs) varied significantly across strains (Table 2.1). 
Compared to respective air controls, the greatest increase in PMNs was found in 
PWD/PhJ, P/J, and PWK/PhJ strains, and the fewest PMNs were found in BTBR T+tf/J, 
SWR/J, and RIIIS/J mice (Figure 2.3A). The greatest mean numbers of hyperoxia-
induced BALF macrophages were found in NZW/LacJ, BALB/cJ, and BTBR T+tf/J 
mice, and the lowest numbers of macrophages were found in MOLF/EiJ, I/LnJ, and 
CAST/EiJ mice (Figure 2.3B).  Similarly, the greatest mean numbers of hyperoxia-
induced epithelial cells were found in A/J, P/J, and C57BL/10J mice, while the lowest 
numbers were found in MOLF/EiJ and I/LnJ mice (Figure 2.3C).  Monocytes, 
lymphocytes, and eosinophils  were not found in the BALF in air controls or after 
hyperoxia exposure. Heritability of the BALF cell types ranged from 39.8% (epithelial 
cells) to 55.7% (macrophages) (Table 2.2).   
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Compared to respective air controls, hyperoxia caused statistically significant 
increases in mean BAL protein concentration (an indicator of lung permeability) in all 
strains (Table 2.1). However, the amount of hyperoxia-induced increase in BAL protein 
varied significantly between strains, ranging from 64.9±6.3 µg/µl in BALB/cByJ to 
241.1±15.0 µg/µl in C3H/HeJ (Figure 2.3D).   
 
Correlation of hyperoxic lung injury phenotypes 
The correlation of phenotypes across strains was evaluated to provide better 
understanding of disease pathogenesis and potential mechanisms of injury. Mean 
numbers of BALF total cells, macrophages and epithelial cells, but not PMNs or protein, 
were significantly correlated with each other in the baseline air control groups as 
measured by the Pearson’s R correlation coefficients. After exposure to hyperoxia, a 
weak but statistically significant correlation was found between PMNs and protein, and  
total cell counts, macrophages, and epithelial cells were also significantly correlated 
(Figure 2.4). However, no other statistically significant correlations were found. 
 
Histopathology of hyperoxic lung injury in neonatal mice 
 Lung maturation and injury were compared by histopathology in hyperoxia-
resistant 129S1/SvImJ neonates and -responsive C3H/HeJ and PWD/PhJ neonates. 
Similar lung development (branched septa and multilobular alveoli) was found in each of 
the air-exposed strains by postnatal day 4 (Figure 2.5). However, strain-specific variation 
in lung injury was found following 72 hours of hyperoxia. Minimal differences in 
peribronchiolar edema were found in hyperoxia-exposed 129S1/SvImJ neonates 
23 
 
compared to air controls. More severe injury characterized by vascular leakage and 
inflammatory cell influx was found in C3H/HeJ lungs, and alveolar edema, compensatory 
proliferation, and thickened alveolar septae were found in PWD/PhJ lungs.   
 
Gene expression in differentially responding strains 
 To further understand differential susceptibility to the pathogenesis of hyperoxic 
lung injury in neonatal inbred mice, we examined gene expression in whole lung tissue 
homogenates from susceptible (C3H/HeJ, C57BL/6J) and resistant (129S1/SvImJ, 
BALB/cByJ) mice at postnatal day 4 in air control and hyperoxia exposed groups. 
Transcript intensity values for each strain were normalized to matched air controls and 
then were compared using GeneSpring software to determine hyperoxia-induced changes 
in transcript expression in all strains (Figure 2.6, Table 2.2). This yielded 103 gene 
transcripts that were analyzed by K-means clustering, which identified 6 clusters of 
differentially expressed transcripts (Figure 2.7). Clusters 1and 6 contain transcripts that 
were upregulated in susceptible strains compared to resistant strains. Cluster 4 included 
genes that were downregulated in susceptible strains, and Clusters 2, 3, and 5 had strain 
specific patterns, such as downregulated genes in BALB/cByJ in Cluster 2.  
 IPA was then used to determine molecular, cellular, and physiological functions 
thatwere attributable to this gene set. Gene function categories that exceeded the 
enrichment threshold ranged from tissue development, cellular assembly and 
organization, and cellular function and maintenance (highest –Log P-value) to immune 
cell trafficking (lowest –Log P-value) (Figure 2.8). Furthermore, a number of gene 
networks (genes interacting with each other in various pathways) were identified that 
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included a significant number of the genes from the GeneSpring analysis. The most 
significant network, titled cardiovascular cell function and maintenance (Figure 2.9), 
contained nuclear factor κ B (NFκB) as its central factor and included major proteins 
such as transforming growth factor β (TGFβ), matrix metalloproteinase 3( MMP3), and 
angiopoietin 2 (ANGPT2). The cellular assembly and organization network (Figure 2.10) 
centered on mitogen-activated protein kinase (MAPK) and included protein kinase B 
(Akt), interleukin -1 (IL-1), extracellular-related kinase 1/2 (ERK1/2), c-Jun N-terminal 
kinase (Jnk), and interleukin-12 ( IL-12). A third network, cellular development and 
growth (Figure 2.11), centered on TGFβ, and contained homeobox protein Hox-A2, 
integrin linked kinase (ILK), and cysteine and glycine-rich protein 1 (Csrp1).  
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Discussion 
Understanding the genetic factors that contribute to BPD has been difficult due in 
part to lack of an adequate and appropriate model. Changes in inflammatory cell 
populations, alveolar epithelial cell death, and hyperpermeability or edema have been 
described for BPD, however these characteristics are not consistent between studies (31, 
32, 97). For example, neutrophil influx has been described as an important part of the 
inflammatory response in the preterm lung; however, biomarker studies for neutrophils in 
BPD, such as lactoferrin and granulocyte-specific S100 calcium-binding protein in 
tracheal aspirates, have shown that neutrophil influx is not consistently observed in 
preterm lungs in relation to development of BPD (35, 98, 99).  Macrophage activation is 
consistently reported in BPD as characterized by cytokine levels (IL-8, IL-6, and IL-1β) 
in tracheal aspirates, but the timing and intensity of the macrophage response varies as 
cytokine profiles vary (6, 35, 100, 101). Reports describe increased epithelial 
permeability in neonatal lung disease, however the occurrence and severity of epithelial 
lesions is irregular (102-104). Because BPD is an unpredictable disease with pathologies 
that are not fully understood, a critical need for animal models to understand lung 
inflammation and injury in the developing lung and the role of genetics has been 
recognized (90). 
In the neonatal inbred mouse model of hyperoxia-induced lung injury, we have 
found response phenotypes similar to those reported in clinical studies. This was 
demonstrated by the unique strain distribution pattern for each of the phenotypes and the 
lack of correlation between them. Although each phenotype was affected by hyperoxia 
exposure, the timing and relatedness of each phenotypic event was not the same. For 
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example, it has been reported that neutrophils are recruited early in lung injury by 
activated resident alveolar macrophages and bronchial and alveolar epithelial cells via 
release of chemotactic factors such as IL-8. Epithelial cell lesions are typically found 
subsequent to the initial injury leading to loss of barrier integrity and alveolar leak. 
However, in the mouse model the timing and mechanism of response to hyperoxia was 
strain specific which suggested a strong role for genetic background.   
 Characterization of oxidant injury in adult rodents has been critical to gain insight 
into respective mechanisms and phenotypes of injury, in addition to genetic 
susceptibility. Studies conducted by Hudak et al. (105) and Whitehead et al. (89) with 
several strains of adult inbred mice described inter-strain variation in hyperoxia-induced 
epithelial hyperpermeability and inflammatory responses and showed that, relative to 
other strains, C3H/HeJ mice were resistant. Interestingly, as neonates, C3H/HeJ mice 
were relatively susceptible to hyperoxia-induced lung injury compared to other strains. 
Similarly, hyperoxia-induced increases in BALF protein concentration were significantly 
increased in adult male BALB/cJ and C57BL/10J mice while minimal increases in BALF 
protein were found in neonates of these strains. Another study that investigated 
differential responses to hyperoxia across multiple inbred mouse strains found adult 
female C3H/HeJ mice to be resistant to hyperoxia as they had increased survival times 
compared to other strains of mice, such as 129S1, which we found to be resistant as 
neonates (88).  Vancza et al (106) also described age-dependent effects following ozone 
(O3) exposure and, as with hyperoxia, C3H/HeJ neonates were very susceptible to O3 but 
were resistant as adults. Recently, age important differences have also been highlighted in 
other models of lung injury and disease, including respiratory syncytial virus, particulate 
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matter exposure, and cigarette smoke exposure (107-109).  Together, these observations 
suggest that genetic factors contribute to susceptibility to hyperoxic lung injury, but age 
is also an important determinant. 
Strain specific response to oxidant injury was further supported by the 
comparative gene expression studies in 129S1/SvImJ, BALB/cByJ, C3H/HeJ, and 
C57BL/6J neonates after hyperoxia exposure. Using IPA, we identified development and 
morphology of cells, tissues, and organs as some of the the significant physiological 
functions variably affected by hyperoxia exposure across strains. Coincidentally, Soutiere 
et al. (110) described differences in lung structure through development in C3H/HeJ and 
C57BL/6J neonates, supporting the assertion that genetics underlie differences in lung 
development and injury. Gene networks containing a significant number of differentially 
expressed genes were also identified. Interestingly, many of the key genes identified in 
these networks, such as NFκB, TGFβ, MMP3, ANGPT2, IL-1, IL-12, TGFβ, integrin 
linked kinase, and cysteine and glycine-rich protein 1, have been implicated in lung 
growth and development and/or BPD (35, 111-116).   
As with all animal models of human disease, there are limitations to the present 
model. Animal models that mimic BPD phenotypes have been developed in rats, mice, 
lambs, piglets and baboons, each of which offers a unique advantage. Larger animal 
models may evaluate risk factors such as volutrauma and barotrauma resulting from 
ventilation and pre and postnatal infection in disease development. Compared to humans, 
baboons are more similar than other models as the length of gestation and induced 
preterm birth as well as lung development (alveoli are present at birth) closely matches 
that of the human fetus. Typically, a baboon delivered at 125 days of gestation (67% of 
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term) is at the lower limit of viability and saccules are barely present in the lung. 
Antenatal glucocorticoids, exogenous surfactant, and various respiratory support 
strategies are needed for survival and long term effects include abnormal vascularization 
and impaired alveolarization, as in human infants with BPD (51, 117, 118). The preterm 
lamb and rabbit are also more comparable to humans than are rodents in terms of 
gestation and lung development and have illustrated the association between 
chorioamniotis and prenatal infection with impaired lung development (119-121). 
Rodents differ from humans in lung development because there are no alveoli present at 
birth. Studying a combination of risk factors is also difficult in mice and rats. However, 
advantages of rodents are that they are cost effective, have short gestation, and breed 
efficiently. Further, mice are invaluable for genetic studies because of the availability of a 
plethora of genetically diverse strains and genetic/genomic tools to identify susceptibility 
genes and gene networks.  
In summary, we have described a murine genetic model of neonatal hyperoxic 
lung injury with inflammatory responses that resemble phenotypes found in clinical BPD. 
Significant inter-strain variation in hyperoxia-induced response phenotypes and gene 
expression indicate genetic background is an important determinant of susceptibility. A 
great utility of this model is that it can be used to elucidate more precise genetic 
mechanisms of disease susceptibility. Subsequent chapters will present genetic and 
genomic studies that provide insight into postnatal lung development and susceptibility 
that are not practical in other animal models but may have important translational 
relevance to human neonatal lung disease.   
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Figure 2. 1 Relatedness of inbred strains of mice. Inbred mice are divided into 7 
groups based on evolutionary relationships. Group 1: Bagg albino derivatives; Group 2: 
Swiss mice; Group 3: Japanese and New Zealand mice; Group 4: C57 and C58 strains; 
Group 5: Castle’s mice; Group 6: Little’s DBA and related strains; Group 7: wild-derived 
strains. Strains underlined in blue were used for genomic analysis of hyperoxic lung 
injury in neonatal mice. Adapted from Petkov et al. Genome Research 14 (2004). 
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Figure 2. 2 Exposure schematic. Litters were delivered spontaneously (postnatal day 0, 
P0) and pooled and randomly assigned to exposure groups on P1. Neonates were 
anesthetized after 72 hours of hyperoxia or air exposure. Lung injury phenotypes and 
histopathology were evaluated. 
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Figure 2. 3 Strain distribution patterns of lung injury phenotypes from BALF after 
72 hours exposure to hyperoxia. (A) PMNs (percent of total cells), (B) Total numbers 
of macrophages (cells/µl BALF), (C) Total numbers of epithelial cells (cells/µl BALF), 
(D) Protein concentration (µg/µl BALF). Means ± SEM are shown (n = 5-28/strain).  
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Figure 2. 4 Pearson’s correlation coefficients for lung injury phenotypes. Positive 
correlations are shown in red, nearing 1.0. Negative correlations are shown in blue. P4: 
Air, PE3: 72 hours hyperoxia. 
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Figure 2. 5 Histopathological responses to hyperoxia exposure in susceptible and 
resistant neonates. Representative H&E stained histopathology images are shown from 
formalin fixed lung of non-responsive 129S1/SvImJ neonates and responsive C3H/HeJ 
and PWD/PhJ neonates. AV, alveoli; BR, bronchiole; BV, blood vessel. Arrows indicate 
pathologies described in the text. 
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Figure 2. 6 Differentially expressed genes following hyperoxia exposure. Gene 
expression profiles in 129S1/SvImJ, BALB/cByJ, C3H/HeJ, and C57BL/6J neonates 
were determined on postnatal day 4 in room air (P4) and after 72 hours hyperoxia 
exposure (PE3). 103 genes were found to be differentially expressed after normalization 
to air controls, p < .05, n = 3/group. 
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Figure 2. 7 K-means cluster analysis of differentially expressed genes. K-means clusters 
analysis was employed to evaluate profiles of differentially expressed genes, and the 6 clusters 
having patterns of biological interest are shown.   
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Figure 2. 8 Classification of hyperoxia-responsive genes. Ingenuity Pathway Analysis was 
used to classify genes with differential expression between strains after 72 hours hyperoxia 
exposure.  
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Figure 2. 9 Cardiovascular cell function and maintenance. Ingenuity Pathway 
Analysis was used to determine networks of genes differentially expressed between 
strains after 72 hours hyperoxia exposure. 
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Figure 2. 10 Cellular assembly and organization. Ingenuity Pathway Analysis was 
used to determine networks of genes differentially expressed between strains after 72 
hours hyperoxia exposure. 
 
 
 
 
 
 
39 
 
Figure 2. 11 Cellular development and growth. Ingenuity Pathway Analysis was used 
to determine networks of genes differentially expressed between strains after 72 hours 
hyperoxia exposure. 
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Table 2.1 Summary of hyperoxic lung injury phenotypes in neonates from 36 strains 
of inbred mice. The phenotypic mean, standard error, and n for each phenotype (P4: air, 
PE3: 72 hours hyperoxia exposure) for each strain are listed. †, significantly different 
from only the highest responding strain, p < 0.05; ‡, different from only the lowest 
responding strain, p < 0.05. 
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Table 2.1 continued.
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Table 2.2 Heritability estimates for lung injury phenotypes measured in neonates 
from 36 strains of inbred mice following 72 hours exposure to hyperoxia.   
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Table 2.3 K-means clusters of differentially expressed genes in hyperoxia-resistant 
and susceptible strains of mice. Differentially expressed genes in 129S1/SvImJ, 
BALB/cByJ, C3H/HeJ, and C57BL/6J were classified into 6 biologically interesting 
clusters and the respective genes are shown. 
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Table 2.3 continued.
 
 
 
CHAPTER 3 
 
HAPLOTYPE ASSOCIATION MAPPING IDENTIFIES CHRM2 AS A 
CANDIDATE SUSCEPTIBILITY GENE FOR NEONATAL HYPEROXIC LUNG 
INJURY 
 
Introduction 
 Survival of low birth weight infants has continued to improve in the past decades 
and the threshold of viability is now approximately 24 weeks of gestation. Significant 
advances in perinatal care including antenatal steroids, surfactant therapy, and mild 
ventilation techniques have made this possible. However, substantial challenges and 
morbidities continue to accompany this progress, the greatest of which is 
bronchopulmonary dysplasia (BPD)(4, 79). BPD is a developmental disease that results 
in impaired alveolarization and abnormal vascularization in the neonatal lung that leads 
to long-term reduction in function. However, research has failed in providing a complete 
understanding of BPD that can be translated into disease prevention (31, 82). 
 Within the last decade, the magnitude of gene-environment interactions 
underlying disease has been realized (122). A genetic component to BPD susceptibility 
was suggested as variation in frequency and severity of disease in preterm infants having 
similar environmental risk factors was found (79). Initial evidence for susceptibility to 
BPD includes gender and race effects as Caucasian male preterm infants have increased 
disease frequency compared to African American and female preterm infants (80). A 
46 
 
twin study indicated an increased risk for BPD in twin pairs independent of a variety of 
other factors such as gestational age and gender (81). Another twin study reported that 
genetic background accounted for 79-82% variation in BPD, and Bhandari et al. 
calculated 53% heritability after controlling for covariates (82, 83). Preterm infants are 
also at greater risk for developing BPD in cases with maternal diabetes, birth asphyxia, 
and familial asthma (37, 84). Polymorphisms in many genes involved in lung 
development, inflammation, and vascularization have been considered in BPD including 
surfactant proteins A and B (SFTPA1B, SFTPB), vascular endothelial growth factor 
(VEGFA), interleukin-1β (IL1B), interleukin-10 (IL10), transforming growth factor β 
(TGFB), insulin growth factor (IGF1), monocyte chemotactic protein-1 (CCL2), 
angiotensin converting enzyme (ACE), glutathione s-transferase (GSTA), and tumor 
necrosis factor α (TNF) (31, 37, 86). Associations between these candidate gene 
polymorphisms and risk of BPD are inconsistent across studies due to lack of statistical 
power, phenotypic heterogeneity, and population admixture (94).  
Several approaches using animal models have been used to elucidate mechanisms 
of neonatal lung disease, and exposure to high concentrations of oxygen (hyperoxia) has 
frequently been used as a model to elicit inflammation and injury phenotypes that 
resemble those found in BPD (31, 117). Animal models have also been utilized to 
investigate the role of genetics in hyperoxic lung injury (88, 105). For example, a role for 
genetic susceptibility in hyperoxic lung injury in adult mice was found by Cho et al. (87).  
In a study where linkage analysis was performed with quantitative response phenotypes 
to hyperoxia exposure, Nrf2 was identified as a candidate susceptibility gene. However, 
genome-wide association or linkage studies have not been done in neonatal mice.  
47 
 
The objective of this study is to better understand genetic factors that contribute to 
neonatal hyperoxic lung injury utilizing the model described in Chapter 2. The model is 
developmentally appropriate as studies in the previous chapter have identified heritable 
susceptibility to hyperoxia-induced inflammation and injury phenotypes. Genome-wide 
haplotype association mapping (HAM) analysis was used to identify quantitative trait loci 
(QTLs) and candidate susceptibility genes that account for genetic variation in neonatal 
hyperoxic lung injury among inbred strains of mice.   
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Methods 
Haplotype association mapping 
In silico HAM was performed on the quantitative phenotype data characterized 
previously (Chapter 2) using SNPster (Genomics Institute of the Novartis Research 
Foundation), Efficient Mixed Model Association (University of California, Los Angeles, 
CA), and FastMap (Carolina Environmental Bioinformatics Center, University of North 
Carolina, Chapel Hill). The algorithms underlying these approaches have been described 
elsewhere (123-126). Briefly, SNPster employs a high-density SNP map (approximately 
650,000 SNPs) to construct haplotypes based on a sliding 3-SNP window. At each 
window throughout the genome, strains are grouped by haplotype and an ANOVA F-
statistic is calculated from the phenotypic means of the groups. This F-statistic is 
weighted to reduce the effect of closely related strains and a generalized family-wise 
error rate (gFWER) is used to account for multiple testing. Default testing conditions for 
SNPster were used (weight estimate = 3, -Log10P threshold = 2.5, SNP window size = 3, 
locus ≥ 2 haplotypes, haplotype group ≥ 3 strains). The algorithm underlying FastMap is 
similar; the primary differences are that a standard F-statistic is used and permutation-
based significance thresholds are determined. EMMA employs a mixed model approach 
to determine genetic associations, which corrects for population structure or genetic 
relatedness.  
 
Animals  
Male and female mice (4-10 weeks) with targeted deletion of Chrm2 (cholinergic 
receptor, muscarinic 2, cardiac, Chrm2-/-) and wild type (C57BL/6NTac, Chrm2+/+) mice 
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were obtained from the National Institute of Diabetes and Digestive and Kidney 
Diseases, Bethesda MD. The Chrm2-/- mice have been described previously (127). Mice 
were caged individually upon arrival and maintained in a 12:12 light:dark cycle at 72°F 
with 50% humidity with food and water provided ad libitum. Mice acclimated to these 
conditions for at least a week prior to mating. Males and females were housed together 
for 3-5 d. Following cohabitation, 1-3 females were housed per cage until pregnancy was 
confirmed. 12-24 hr after spontaneous birth, pups were randomly assigned to air or 
hyperoxia exposure groups. Litters from all strains were cross-fostered with Swiss 
Webster dams (Charles River, Wilmington, MA) to ensure adequate and consistent 
maternal care. Animal procedures were approved by the NIEHS IACUC.  
 
Hyperoxia exposure 
Litters with foster dams were maintained for 72 hours in room air or a chamber 
supplied with ≥ 95% oxygen (UHP grade, min. purity 99.994%, National Welders, 
Durham, NC). The chamber was opened for approximately 30 min each morning for 
health checks and cage cleaning. Foster dams were also replaced at this time to avoid 
changes in maternal care due to hyperoxia effects to the dam. After termination of 
exposure, mice were weighed and anesthetized by i.p. injection of sodium pentobarbital 
(104 mg/kg).  
 
Bronchoalveolar lavage 
After anesthetization, the trachea was cannulated in situ, and the whole lung was 
rinsed four consecutive times with 100 µl Hank’s balanced salt solution (HBSS) (n ≥ 
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5/group). Bronchoalveolar lavage fluid (BALF) was kept on ice during necropsy and then 
centrifuged (500xg at 4°C, 10 min). The supernatant was removed and assayed for 
protein concentration using the Bradford method according to the manufacturer’s 
protocol (Bio-Rad, Hercules, CA). The cellular pellet was resuspended in 500 µl ice cold 
HBSS with 5% BSA, and total cell counts were obtained with a hemocytometer. 
Cytospins were prepared using 200-300 µl of the cell suspension and stained with 
Wright-Giemsa stain (Fisher Scientific, Pittsburgh, PA). Differential cell counts for 
macrophages, epithelial cells, and neutrophils were performed by identifying 300 cells 
according to standard cytological techniques.  
 
Lung histopathology 
After anesthetization, the whole lung was fully inflated intratracheally in situ with 
zinc formalin (Fisher Scientific, Pittsburgh, PA). The trachea was clamped and the lung 
removed and immersed in zinc formalin for 48 hrs. Fixed lungs were then placed in 70% 
ethanol until embedded, sectioned, and stained (hematoxylin and eosin) for pathological 
assessment.  
 
Statistics 
One-way analysis of variance was used to compare haplotype means, and 
Student’s T-test was used to compare strains with Chrm2 P265L alleles. Statistical 
significance was accepted at p < 0.05.   
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Results 
Haplotype association mapping with disease phenotypes 
Previous studies (see Chapter 2) identified statistically significant inter-strain 
variation in hyperoxia-induced changes in BALF total cells, macrophages, PMNs, 
epithelial cells, lymphocytes, and total protein concentration. To better understand the 
genetic basis of differential susceptibility to hyperoxia exposure in neonates, we used 
genome-wide HAM for each lung injury phenotype in the 36 inbred strains. HAM of 
hyperoxia-induced increases in BALF macrophages using SNPster identified loci on 
chromosomes 1, 4, 7, and 9 with -Log10P values greater than 5 (Table 3.1). The same 4 
loci were also identified using FastMap, and EMMA, and have been named hyperoxia 
susceptibility in neonatal lungs (Hsnl)1, Hsnl2, Hsnl3, and Hsnl4, respectively. HAM of 
hyperoxia-induced increases in BALF PMNs identified a peak on chromosome 6 with a –
Log10P value of 4.60, and peaks on chromosomes 2 and 7 with            –Log10P values 
greater than 3.97 (Figure 3.1, Table 3.1). As with the macrophage phenotype, these three 
loci for the PMN phenotype were also identified using FastMap and EMMA, and they 
have been named Hsnl5, Hsnl6, and Hsnl7. HAM analyses of the other hyperoxia 
response phenotypes with SNPster did not identify peaks greater than –Log10P greater 
than 3.70, or were not identified using FastMap or EMMA.  
 
Identification of candidate susceptibility genes 
We next queried the Mouse Phenome Database (http://phenome.jax.org; The 
Jackson Laboratory) for informative single nucleotide polymorphisms (SNPs) in genes 
located within the peaks identified by HAM to determine whether one or more of the 
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SNPs associated with susceptibility to hyperoxia-induced lung injury among the inbred 
strains of mice. The minor allele SNPs must have been present in at least 10% of all the 
inbred strains to be considered for further analysis. The gene Cntnap5b (contactin 
associated protein-like 5b) is located in Hsnl1 and non-synonymous coding SNPs that 
cause amino acid substitutions were identified (Table 3.2). Hyperoxia-induced changes in 
BAL macrophages were significantly greater in strains homozygous for the minor allele 
of the SNPs compared to strains homozygous for the major allele (Table 3.2). Four 
cytochrome P450, family 2, subfamily j, polypeptide genes (Cyp2j11, Cyp2j6, Cyp2j9, 
and Cyp2j5) were found in Hsnl2, and non-synonymous coding SNPs that cause amino 
acid substitutions were found in each gene that associated with significantly greater 
hyperoxia-induced macrophage numbers among strains homozygous for the minor alleles 
(Table 3.2). O-6-methylguanine-DNA methyltransferase (Mgmt) is located in Hsnl3, and 
two non-synonymous coding SNPs in exons 2 and 3 were significantly associated with 
differential susceptibility to hyperoxia among the 34 strains. 
We also used this search strategy to query Hsnl4 for hyperoxia susceptibility 
genes, and Chrm2 (cholinergic receptor, muscarinic 2, cardiac) was found directly 
beneath the peak of Hsnl4 (Figure 3.2). The haplotype structure for synonymous and non-
synonymous coding SNPs was investigated, and three Chrm2 haplotypes containing at 
least 3 strains were identified (Figure 3.3A). Significantly greater hyperoxia-induced 
changes in BALF PMNs were found in mice with Chrm2 haplotype 1 compared with 
haplotypes 2 and 3, and the PMN response to hyperoxia was significantly greater in mice 
with Chrm2 haplotype 2 compared with haplotype 3 (Figure 3.3B). Furthermore, the 
nonsynonymous CT coding SNP located at 36.474006Mb (rs30378838) in exon 1 
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causes replacement of the proline residue at position 265 with a leucine residue (Figure 
3.2B), and significantly (P<0.0001) reduced numbers of BALF PMNs were found in 
mice homozygous for T allele (9.4±0.9 % PMNs/ul) compared to strains homozygous for 
the C allele (4.0±0.5 % PMNs/ul; Figure 3.3C, Table 3.2).  
 
Targeted disruption of Chrm2 reduces hyperoxia-induced lung injury 
We further investigated the role of Chrm2 in this model by comparing the 
response to hyperoxia exposure in Chrm2+/+ and Chrm2-/- mice. No statistically 
significant differences in any of the BALF phenotypes were found between Chrm2+/+ and 
Chrm2-/- mice after air exposure. However, 2-way ANOVA found statistically significant 
genotype, exposure (72 hr hyperoxia), and interaction effects on BALF protein 
concentration (Figure 3.4A). Relative to respective air-exposed controls, mean BALF 
protein concentration was significantly increased in Chrm2+/+ neonates, but no increase 
was observed in the Chrm2-/- neonate lungs. Further, hyperoxia-induced BALF protein 
concentration was significantly greater in Chrm2+/+ mice compared to Chrm2-/- mice. 
Hyperoxia effects were found for other BALF phenotypes, but no genotype effects were 
detected (data not shown). H&E staining of air- and hyperoxia-exposed Chrm2+/+ and 
Chrm2-/- mice supported the BALF results. No differences in histopathological 
characteristics were found between Chrm2+/+ and Chrm2-/- mice after air exposure 
(Figure 3.4B). However, increased edema in the alveoli and enhanced bronchial epithelial 
and alveolar septal proliferation were found in Chrm2+/+ compared to Chrm2-/- neonates 
after 72 hyperoxia exposure.  
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Discussion 
Studies in clinical cohorts of BPD infants have yielded an extensive list of 
potential biomarkers that associate with disease, yet there is no biomarker (or well-
characterized genetic determinants) for early detection of BPD. The biomarkers proposed 
from studies in clinical cohorts and some animal models are inconsistent and generally 
lack a causal relationship to BPD. This is the first study to evaluate hyperoxia-induced 
lung injury phenotypes in neonates across a genetically diverse panel of inbred strains. 
The large number of inbred strains phenotyped and described in Chapter 2 enabled 
leverage of a rich and expanding SNP database for HAM analyses. Our HAM analysis 
provided an initial understanding of genetic factors contributing to development of 
hyperoxic lung injury in an age-relevant animal model. QTLs were identified on 
chromosomes 1, 2, 4, 6, 7, and 9 (Table 3.1) and further investigation of these genomic 
regions yielded many SNPs with potential relevance to neonatal hyperoxic lung injury.  
After we identified the susceptibility QTLs, we queried the QTL peaks for 
candidate genes and informative SNPs. While it may be important to consider all the 
various types and locations of SNPs within the candidate genes identified in the present 
study, we limited our initial search to promoter and non-synonymous coding SNPs as a 
means to prioritize candidate genes for further investigation. These SNPs generally have 
the most obvious impact on disease phenotypes because they cause an amino acid change 
in the encoded protein, which can significantly alter protein function and stability (128). 
Likewise, a promoter SNP can alter transcript levels for its respective gene by modifying 
the affinity of transcription regulatory elements for the promoter. However, this does not 
mean that intronic SNPs are not without consequence. Though we do not fully understand 
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all of the roles of introns in the genome, recent studies have shown their importance in 
regulating gene splicing and coding for micro-RNAs, and intronic SNPs have been linked 
to disease through these mechanisms (129-131).  
In the present study, Cyp2j6, Mgmt, and Chrm2 were identified as candidate 
susceptibility genes because of their phenotypic association and biological plausibility in 
oxidative- and immune-mediated stress responses.  Cyp2j6 has been implicated as an 
anti-inflammatory mediator in acute allergic inflammation in the airways of ovalbumin 
challenged mice and has a human ortholog, CYP2J2 (132, 133). Furthermore, studies of 
human CYP2J2 in vitro have demonstrated that its epoxygenase activity converts 
arachidonic acid into anti-inflammatory epoxyeicosatrienoic acids, which can induce 
PPARα and -γ activation and lead to inhibition of NF-κβ and MMP-9 activity (134-136). 
While investigations on CYP2J2 provide suggestive evidence for a role for Cyp2j6 in 
airway injury, mechanistic similarities of these homologs must be validated.  
Another candidate gene, Mgmt, encodes O-6-methylguanine-DNA 
methyltransferase, which is involved in DNA repair through removal of alkyl or methyl 
adducts of guanine. MGMT polymorphisms have been well described in various cancers 
and contribute to epigenetic alterations (137). A specific role for Mgmt in development 
has not been elucidated, but it is reasonable to consider that it may have important 
implications as epigenetic alterations play a critical part in developmental origins of lung 
disease (138). Joss-Moore et al. (138) have described epigenetic alterations in the 
developing lung resulting from perinatal insult, including mechanical ventilation with 
supplemental oxygen, that affect expression levels of elastin, VEGF, and PPARγ, all of 
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which have a role in normal lung development. Thus, further investigation of Mgmt 
polymorphisms may yield a novel epigenetic role in neonatal hyperoxic lung injury.  
Chrm2 encodes for the M2 muscarinic g-protein coupled receptor which is a 
member of the cholinergic muscarinic receptor family. These receptors modulate airway 
reactivity and have been intensely studied in pathogenesis of allergies and asthma. More 
recently a new role of the muscarinic receptors has been found in non-neuronal 
cholinergic signaling (139, 140). Of particular interest were recent investigations that 
reported the influence of muscarinic receptor activation on release of pro-inflammatory 
cytokines in smooth muscle cells, bronchial epithelial cells, and alveolar macrophages 
(141-143). For example, it has been demonstrated that human airway smooth muscle 
cells, in vitro, secrete proinflammatory IL-8 when exposed to methacholine and cigarette 
smoke exctract (142). Profita et al. (144) demonstrated altered expression of the M2 
muscarinic receptor in sputum cells collected from subjects with COPD. Moreover, a role 
for muscarinic receptors in vascular leak has been described (145). Neuroimmune cross-
talk has been suggested as a regulatory mechanism of inflammation and infection (146-
148). For example, Rosas-Ballina et al. (148) found acetylcholine acts on splenic 
macrophages to inhibit production of proinflammatory tumor necrosis factor α. The role 
of muscarinic receptor expression on inflammatory cells is still unknown.  
A potential role for Chrm2 in differential susceptibility to hyperoxia-induced 
neonatal lung injury was supported by two lines of evidence. We initially found that 
haplotype structure of Chrm2 as well as a non-synonymous Chrm2 SNP C265T 
associated with differential susceptibility to hyperoxia-induced inflammation and lung 
injury. The C265T substitution is found within the third intracellular loop of the 
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transmembrane receptor, which is essential for specificity in muscarinic receptor activity, 
and based on structural prediction, the replacement of a proline with a leucine residue is 
likely to have a functional effect. Additional investigation is required to validate the 
functional prediction. The second line of supportive evidence for Chrm2 as a 
susceptibility gene in this model is that, relative to wild-type mice, targeted deletion of 
Chrm2 significantly reduced hyperoxia-induced neonatal lung injury. Together, these 
studies support the hypothesis that Chrm2 is an important determinant of neonatal lung 
injury and inflammation phenotypes induced by hyperoxia. Future studies are necessary 
to identify the mechanism through which Chrm2 modulates the hyperoxia response.  
Other genes within the identified QTLs include Cntnap5b, Fat3, Cyp2j11, 
Cyp2j9, and Cyp2j5; however, a role for these genes in hyperoxic lung injury is not as 
easily hypothesized. The cytochrome P450 genes do not have human orthologs, and so 
their importance to any hyperoxia responses in mice would not be implicated in humans. 
The biological roles of Fat3, or FAT tumor suppressor homolog, are not fully understood. 
While it is known that it is a large protein containing many EGF and cadherin-like 
domains, it has only been suggested that Fat3 is involved in axon guidance and 
modulation of extracellular space during embryonic neuronal development (149, 150). 
Cntnap5b encodes contactin associated protein-like 5b which is a member of the neurexin 
family of genes that are important in cell-cell interaction and signaling in the nervous 
system (151). While Cntnap5b has been linked to autism, dyslexia, and bipolar disorder, 
a role for this gene beyond the nervous system has not been previously described (152, 
153).  
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In summary, HAM identified QTLs for hyperoxia-induced inflammation in the 
neonate mouse lung. Candidate susceptibility genes, including Chrm2, were identified in 
the QTLs. Results of studies with neonatal mice deficient in Chrm2 were consistent with 
the hypothesis that Chrm2 contributes to the pathogenesis of hyperoxic lung injury. 
Further investigation is required to elucidate the role of other candidate susceptibility 
genes and to better understand the exact mechanism by which Chrm2 modulates 
hyperoxia response and its relevance in human cohorts. Results of these studies may have 
important implications for identification population at risk of neonatal lung injury and 
may provide therapeutic target through which injury may be prevented.  
 
 
 
 
 
 
 
 
 
59 
 
Figure 3. 1 Genome-wide haplotype association mapping. Manhattan plots are shown 
from HAM with SNPster for the BALF hyperoxic lung injury phenotypes: 
polymorphonuclear lymphocytes (A), macrophages (B), epithelial cells (C), and protein 
concentration (D). 
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Figure 3. 2 Polymorphonuclear lymphocyte QTL, Hsnl6. A. The QTL on 
chromosome 6 ranges from 35.75 to 36.71 Mb. The gene directly beneath the significant 
peak with a –Log10P value of 4.6 is Chrm2, which encodes the M2 muscarinic receptor. 
B. The SNP at 36.474006 Mb, rs30378838, causes a proline residue to be replaced with 
leucine within the 3rd intracellular loop, shown by the simplified schematic of muscarinic 
receptors.  
 
A. 
 
B.  
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Figure 3. 3 Haplotype structure and the association of Chrm2 with susceptibility to 
hyperoxia-induced BALF PMNs. A. Truncated haplotype structure of Chrm2 with 
synonymous (Cs) and non-synonymous (Cn) coding single nucleotide polymorphisms 
(SNPs) in strains of mice phenotyped for response to hyperoxia and ordered by similar 
haplotype. rs30378838 causes a substitution of  proline at position 265 with leucine. The 
shaded gray boxes indicate strains within the three haplotype blocks. B. The mean 
number of BALF PMNs (percent of total cells) in strains of mice with CCT (n=3), GCC 
(n = 17 strains), and CTT (n = 14 strains) Chrm2 haplotypes. C. The mean number of 
BALF PMNs for strains homozygous for the rs30378838 C allele (n = 21) and strains 
homozygous for the T allele (n = 15 strains). ** p < 0.01; ***, p < 0.001. 
A.  
 
 
B.                  C.  
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Figure 3. 4 Pulmonary responses to hyperoxia or air exposure in Chrm2+/+ and 
Chrm2-/- neonates. A. BALF protein concentrations (µg/µl). B. Representative H&E 
stained histopathology images. Means  SEM are shown. N = 6-12/group. AV, alveoli; 
BR, bronchiole; BV, blood vessel. *, p < 0.05 vs respective air exposed mice. +, p < 0.05 
vs Chrm2+/+ mice. 
A.  
 
B. 
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Table 3.1 QTLs for hyperoxia-induced inflammation identified by haplotype 
association mapping in 36 neonate inbred mouse strains. QTLs were identified for 
BAL macrophages and neutrophils after 72 hr exposure to hyperoxia. QTLs were named 
Hyperoxia susceptibility in neonatal lungs (Hsnl). Chromosomal locations (Mb) and –
Log10P values are indicated. 
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Table 3.2 Candidate susceptibility genes in QTLs for hyperoxia-induced 
inflammation in neonate mouse lungs. Candidate susceptibility genes are indicated 
according to QTL. All SNPs resulting in an amino acid (AA) change are listed for each 
gene. The means and standard error of the BAL phenotypes for the respective QTL in 
strains having the major or minor allele are reported. The P value reported indicates the 
genotype-phenotype association for the respective SNP (*, p<0.01; **, p<0.001). 
 
 
 
QTL Gene Symbol Gene Name SNP ID Location (Mb) 
(Build 37)
AA 
change
Major allele 
mean (SEM)
Minor allele 
mean (SEM)
P -value
rs33137464 101.863790 E 69 A A 11049 (1055) C 21873 (4398) 0.0001
rs50008449 102.375045 H 1167 Y C 21518 ( 1865) T 8473 (2292) 0.0210
Cyp2j11 cytochrome P450, family 2, 
subfamily j, polypeptide 11
rs28105241 95.961592 I 476 V T 21615 (1813) C 7699 (2565) 0.0133
Cyp2j6 cytochrome P450, family 2, 
subfamily j, polypeptide 6
rs28120055 96.202243 C 192 F C 21615 (1813) A 7699 (2565) 0.0133
Cyp2j9 cytochrome P450, family 2, 
subfamily j, polypeptide 9
rs28119885  
rs28119867
96.252622         
96.257924
I 90 V        
R 37 L
T 22084 (1835)   
C 21827 (1796) 
C 7572 (1991)   
A 6007 (1588)
0.0111   
0.0043
Cyp2j5 cytochrome P450, family 2, 
subfamily j, polypeptide 5
rs28119831 96.300844 P 394 T C 21827 (1796) A 6007 (1588)   0.0043
Hsnl 3 Mgmt O-6-methylguanine-DNA 
methyltransferase
rs33644808  
rs33669425
144.143061        
144.277666
L 32 F        
G 53 C
G 22084 (1835)   
G 24824 (2585)
T 7572 (1991)   
T 14124 (1528)
0.0111    
0.0020
Hsnl 6 Chrm2 cholinergic receptor, 
muscarinic 2, cardiac
rs30378838 36.474006 P 265 L C 9.4 (0.9) T 4.0 (0.6) <0.0001
Single nucleotide polymorphism
Hsnl 2
Hsnl 1 Cntnap5b contactin associated protein-
like 5b
 
 
CHAPTER 4 
 
INTER-STRAIN VARIATION IN POSTNATAL LUNG GENE EXPRESSION 
AND DEVELOPMENT IN INBRED MICE 
 
Introduction 
 In the past decade genome-wide association studies (GWAS) have been used to 
identify functional genetic variants that underlie disease susceptibility (154). As of 2011, 
1,449 GWAS have been published on human disease, yet advances in understanding the 
genetic contribution to these various diseases is limited (155, 156). There are many 
challenges to the success of GWAS including population stratification, rare alleles, 
genetic heterogeneity, variable environmental factors, and limitations on experimental 
validation, thereby supporting a case for the use of model organisms, most often the 
mouse, for human disease research (94, 95, 154, 157).  
 The success of using mouse models to identify genetic factors contributing to 
disease traits has also been challenging. GWAS or haplotype association mapping 
(HAM) in mice often results in QTLs containing a large number of genes, making it 
difficult to identify the causative SNP (158, 159). Furthermore, the relevance of the 
causative SNP to the disease phenotype is frequently not understood (156). Chapter 3 
detailed an approach limiting candidate gene identification to those containing 
nonsynonymous coding SNPs, but this excludes the consideration of other variants that 
may significantly contribute to the disease phenotype. 
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The objective of QTL investigations is to identify genomic loci that associate with 
disease. However, there are several possible mechanisms by which genetic variants can 
be linked to disease through indirect relationships. Integrating genetics and genomics in 
expression QTL (eQTL) analysis provides an important method to evaluate how genetic 
variation at a genomic locus can lead to modifications in transcripts within gene 
networks, which may in turn lead to variation in the disease phenotype (160). While 
nonsynonymous SNPs identified in QTL analysis have yielded significant results, linking 
variation in gene expression to disease susceptibility should provide further mechanistic 
understanding (161).   
The need to understand the developmental processes of the lung and the 
associated regulatory and signaling pathways in addition to how expression of genes 
involved in inflammation and injury differ between uninjured and injured lung has been 
recognized, yet little progress has been reported (90). The objective of the present chapter 
is to investigate differential gene expression in postnatal lung development and identify 
associated eQTLs and correlations between gene expression in postnatal lung 
development and hyperoxic lung injury phenotypes. Chapter 5 will build on these results 
and address variation in gene expression in postnatal lung from 30 strains of mice 
following hyperoxia exposure. This combined approach of genetic genomics and 
bioinformatics should contribute to better understanding postnatal lung development and 
susceptibility to lung injury.  
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Methods 
Animals 
Male and female mice (4-10 weeks) from 30 inbred strains were studied (The 
Jackson Laboratory, Bar Harbor, ME). Strains were chosen to maximize genetic diversity 
(Figure 4.1). Upon arrival, animals were caged individually, maintained in a 12:12 
light:dark cycle at 72°F with 50% humidity, and provided food and water ad libitum. 
Mice acclimated to these conditions for at least a week prior to mating. Males and 
females were housed together for 3-5 days. Following mating, males were removed and 
1-3 females were housed per cage until pregnancy was confirmed. After spontaneous 
birth, the pups were cross-fostered with Swiss Webster dams (Charles River, 
Wilmington, MA) to ensure adequate and consistent maternal care. Litters with foster 
dams were maintained in room air, and on postnatal day 4, three pups per strain were 
weighed and sacrificed by i.p. injection of sodium pentobarbital (104 mg/kg). Lungs were 
removed and homogenized before snap freezing. Additionally, for 129S1/SvImJ, 
BALB/cByJ, C57BL/6J, and C3H/HeJ mice, three pups were similarly sacrificed and 
lungs collected on postnatal days 1, 2, 3, and 4 (P1-P4). All animal use was approved by 
the NIEHS Animal Care and Use Committee. 
 
RNA isolation 
 Whole lungs were collected in triplicate in all cases and snap frozen as described 
above and stored at -80°C until processed. RNA was extracted from approximately 20 
mg of frozen lung tissue using the RNeasy Plus Kit, the Tissuelyser LT, and the QIAcube 
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according to the manufacturer’s protocol (Qiagen, Valencia, CA). RNA quality was 
verified (A260/A280 > 1.8) and provided to the NIEHS Microarray Core (NMC). 
 
Illumina genechip analysis 
Microarray hybridization was conducted in the NMC with lung homogenates 
from 30 strains of mice (Figure 4.1) on postnatal day 4 using Illumina Sentrix Beadchip 
Mouse WG-6 v2 arrays (Illumina, Inc., San Diego, CA) following the Illumina Whole-
Genome Gene Expression Direct Hybridization Assay Guide. Starting with 250 ng of 
total RNA, biotin labeled cRNA was produced according to Ambion’s Illumina TotalPrep 
RNA Amplification Kit protocol. For each sample, 1.5 µg of biotin labeled cRNA was 
hybridized for 17 hrs in a static hybridization oven. Slides were washed and stained with 
streptavidin-Cy3 according to Illumina’s protocol and then scanned with an Illumina 
BeadArray Reader with BeadScan software (version 3). Probe hybridization intensity 
data were acquired from the arrays using Illumina GenomeStudio software (V2011.1), 
Resolver® system (version 7.1) (Rosetta Biosoftware, Kirkland, WA). 
Initial quality control performed in the NMC utilized principal components 
analysis (PCA) on all samples and all probes to characterize the variability present in the 
data. A batch effect was identified in arrays manufactured in different facilities and was 
minimized by randomizing the samples run on each set of arrays. To further evaluate the 
batch effect present in the data, we collaborated with the Microarray and Genome 
Informatics (MGI) group at NIEHS (Pierre Bushel and Jun Lu, personal communication) 
to employ normalization and batch correction strategies. To this end, the raw expression 
data were quantile normalized (probe ranked by their expression) within replicates and 
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scaled by median (to 150) across all samples. The batch correction was then performed 
on the Log2 transformed normalized data, based on the following analysis of variance 
(ANOVA) model: 
 
Yijkl = µ + αi + βj + (αβ)ij + Yk + εijkl, for i = 1,…,30, j = 1,2, k = 1,2 and l = 1,2,3 
 
The parameters αi correspond to the effects of the strains, the βj corresponds to the 
treatment effects, the parameters (αβ)ij are the interaction of the strain by treatment, and 
the parameters Yk correspond to the batch effects. The estimated batch effects Yk were 
then removed from the observed expression values Yijkl to obtain the normalized and 
batch corrected data. 
e-QTL analysis 
The Illumina raw intensity values were normalized by Log2 transformation prior 
to eQTL analysis in FastMap. eQTL analysis was similar to the HAM described in 
Chapter 3, where the array probes were used as quantitative phenotypes. Briefly, an 
ANOVA was conducted to determine strength of genetic association between the 
normalized probe intensities and the haplotype structure. For each transcript, FastMap 
first generates a P-value for the association between the normalized probe intensities and 
each 3-SNP window by performing an ANOVA.  These P-values are used to calculate 
association scores, which are –Log10P. FastMap then performs a permutation test to 
correct for multiple comparisons. This is done by randomizing the normalized probe 
intensities across the strains and recalculating the association scores, then storing the 
maximum value. This is repeated 1000 times, and a corrected P-value is assigned to each 
association score based on the proportion of permuted scores that are greater (i.e. if 20% 
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of the 1000 tests produce an association score that is higher than the actual score, the 
assigned P-value is 0.2). P-value thresholds were set at 0.05 for significant, 0.2 for highly 
suggestive, and 0.5 for suggestive. cis-eQTLs are those in which a strong association 
exists between the expression of a gene and the locally inferred haplotype and were 
limited to a one megabase (Mb) window centered on the location of the respective SNP.  
 
Affymetrix GeneChip analysis 
The kinetics of gene expression during postnatal days 1-4 were evaluated in lung 
homogenates from hyperoxia-resistant 129S1/SvImJ and BALB/cByJ mice, and 
hyperoxia-susceptible C57BL/6J and C3H/HeJ mice using Affymetrix GeneChip analysis 
(Affymetrix Mouse Genome 430 2.0 platform; Affymetrix, Santa Clara, CA). 500 ng of 
total RNA was amplified using the Affymetrix 3’ IVT Express Kit protocol, running the 
biotin synthesis for 4 hours. 12.5 µg of amplified biotin-cRNAs was fragmented and 10 
µg was hybridized to each array for 16 hours at 45°C in a rotating hybridization oven 
using the Affymetrix Eukaryotic Target Hybridization controls and protocol. Array slides 
were stained with streptavidin/phycoerythrin utilizing a double-antibody staining 
procedure and then washed for antibody amplification according to the GeneChip 
Hybridization, Wash and Stain Kit manual. Arrays were scanned in an Affymetrix 
Scanner 3000 and probe hybridization intensities were acquired using the GeneChip 
Command Console Software (AGCC; Version 1.1) using the MAS5 algorithm to 
generate .CHP files. Background correction, RMA normalization, and PCA were 
performed with the Rosetta Resolver System (Version 7.2, Rosetta Biosoftware, Seattle, 
WA). 
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Comparative gene expression analysis was then performed between responder and 
non-responder strains. Differentially expressed genes were queried between the two 
groups by setting a fold change (FC) cut-off at 1.2 with an adjusted P-value below 0.01. 
Each time point (P1, P2, P3, and P4) was evaluated independently.  
 
Correlation analysis of gene expression and hyperoxic lung injury phenotypes 
To determine significant correlations between transcript levels and hyperoxic lung 
injury phenotypes presented in Chapter 2, a linear regression model was developed (MGI, 
personal communication). The Log2 transformed normalized and batch corrected Illumina 
expression data were acquired as described above. Quantitative phenotype measurements 
from Chapter 2, with the exception of BALF protein, were Log2 transformed prior to 
analysis. To determine the strength of correlation between probes and phenotypes, each 
gene expression chip (1 per animal, 3 animals per strain) was matched to 5 phenotypic 
measurements drawn (i.e. sampled) from a normal distribution where the mean and 
standard deviations were estimated from the observed data. It is assumed that the 
populations are normally distributed and that 1) the population variances are equal 2) the 
data are independent random samples and 3) the random errors follow a normal 
distribution. A linear model was then used to regress each phenotypic measurement on 
the gene expression measured by each probe for the comparison of either a high 
responder (maximum phenotypic mean value) strain or a low responder (minimum 
phenotypic mean value) strain with all other strains. Correlations (between the gene 
expression measured by probes and the sampled phenotype measurements) having a 
nominal P-value at or below 0.0005 were considered less likely to be due to chance.  
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Ingenuity pathway analysis 
 Ingenuity pathway analysis (IPA) (Redwood City, CA) was used to determine 
gene networks and physiological functions associated with gene lists compiled by various 
gene expression analyses in postnatal lungs. Differentially expressed genes in hyperoxia-
resistant and susceptible pups on P1, P2, P3, and P4 were analyzed individually in IPA. 
Genes differentially expressed at each time point were also combined for analysis. IPA 
was also used to describe a combined gene list from QTL, cis-eQTL, and correlation 
analysis.   
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Results 
Variation in gene expression between strains 
Initial gene expression analysis was designed to identify and describe 
differentially expressed transcripts in lungs at postnatal day 4 across 30 strains of inbred 
mice. The Illumina BeadChip platform detects over 45,000 transcripts, approximately 
27,000 of which are coding transcripts (based on Build 36, Release 22). A minimum FC 
of 1.5 yielded 4,513 transcripts having differential expression between at least two strains 
(Figure 4.2A; Supplemental Table 4.1).  
 A FC between 1.5 and 2 was found for most genes when comparing the lowest 
and highest probe intensities among strains (n = 2,977) (Table 4.1; Supplemental Table 
4.1). Fold changes ranging from 6-8 were found for 16 probes, and Actb (encoding 
actinβ) had the greatest difference in expression (FC = 7.80) (Table 4.2). Other genes 
with FC >6 included Lyz1, Ahsg, Serpina1b, Apoa2, S100a8, Apoa1, Myl1, Csrp1, Kng1, 
Ear2, and Ttr (Figure 4.2B). Two mitochondrial transcripts were differentially expressed: 
MTND1, encoding mitochondrial NADH dehydrogenase, and MTATP6, encoding 
mitochondrial ATP synthase 6.   
 
Kinetics of differential gene expression in postnatal lung development  
The kinetics of gene expression in postnatal lung development (days 1-4, P1-P4) 
were assessed in 129S1/SvImJ, BALB/cByJ, C3H/HeJ, and C57BL/6J mice. During 
postnatal days 1-4, saccularization is completed while alveolarization begins, and gene 
expression was compared at each day between resistant (129S1/SvImJ) and susceptible 
(C3H/HeJ) neonates. Transcript expression for 695 genes were significantly different (p< 
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0.01; FC > 1.2) between resistant and susceptible neonates at P1, 422 at P2, 291 at P3, 
and 94 at P4 (Figures 4.3, 4.4; Supplemental Table 4.2). 55 gene transcripts were 
differentially expressed at all time points.  
 Further analysis of differentially expressed transcripts at each time point was done 
using IPA. At P1, the network function having the highest association with P1 genes 
(score of 44) was cellular growth and proliferation/hematological system development 
and function/humoral immune response (Table 4.3, Figure 4.4). The physiological 
functions with greatest enrichment were hematological system development and function, 
immune cell trafficking, and tissue morphology with the number of associated genes 
ranging from 34-70. At P2, 422 transcripts were associated in a network of genes 
involved in antigen presentation/cell-to-cells signaling and interaction/hematological 
system development and function (Table 4.3, Figure 4.4). Hematological system 
development and function, tissue morphology, immune cell trafficking, cell-mediated 
immune response, and hematopoiesis were the strongest associated physiological 
functions. The 291 genes differentially expressed at P3 associate with cellular growth and 
proliferation/cell cycle/cancer biological functions (Table 4.3, Figure 4.4). Embryonic 
development, cardiovascular system development and function, and organismal 
development were the most enriched physiological function classifications. Finally, the 
strongest associated networks at P4 included cellular compromise/DNA replication, 
recombination, and repair/cell-to-cell signaling and interaction with a score of 32. 
Connective tissue development and function, cardiovascular system development and 
function, and embryonic development were the related physiological functions (Table 
4.3, Figure 4.4).  
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Fifty-five gene transcripts were differentially expressed between resistant 
(129S1/SvImJ and BALB/cByJ) and susceptible (C3H/HeJ and C57BL/6J) neonates at 
each time point that were weakly associated with connective tissue development and 
function, cardiovascular system development and function, embryonic development, and 
organismal development (Table 4.3; Figure 4.4) and associated with a network involving 
gene expression/cell-to-cell signaling and interaction/hematological development and 
function.  
 
cis-eQTL analysis of differentially expressed genes at postnatal day 4 
eQTL analyses were employed to identify associations between differentially 
expressed transcripts and SNPs mapped in the murine genome. Log2 transformed 
transcript intensities were used as quantitative phenotypes for HAM in FastMap. Each 
resultant significant association, or peak, found by HAM is an eQTL, and all the 
significant eQTLs found in differentially expressed transcripts in neonatal lungs across 
the 30 strains were plotted (Figure 4.5A). For example, Tnfaip2 (probe ILMN_2841289) 
was differentially expressed across the 30 inbred strains of mice (Figure 4.5B). A total of 
7 significant associations were found in the resultant Manhattan plot the for Tnfaip2 
transcript (Figure 4.5C). One of these associations is cis-acting because Tnfaip2 is found 
directly beneath the peak on chromosome 12. The other peaks on the Manhattan plot are 
trans-elements, meaning non local genomic loci are regulating the expression of Tnfaip2 
(Figure 4.5D). All significant cis-eQTLs (Figure 4.5A) are listed in Table 4.4. 
 
Correlation of gene expression at postnatal day 4 with hyperoxic lung injury phenotypes 
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 To better understand how variation in gene expression at baseline relates to 
hyperoxic lung injury, transcript expression levels and hyperoxic lung injury phenotypes 
(Chapter 2) were correlated. Probe intensities for each strain were compared to the 
respective low and high responding strains for the respective phenotype. When compared 
to low and high responding strains, no significant correlations were found with BALF 
protein (BALB/cByJ and C3H/HeJ), polymorphonuclear leukocyte counts (BTBR T+tf/J 
and P/J), or macrophage counts (BALB/cByJ and 129S1/SvImJ) (data not shown).  
 Significant correlations were found between probe intensities (n = 567) and 
epithelial cell counts, yielding 526 correlated genes. Correlations were determined by 
comparing epithelial cell counts and transcript levels across strains to Molf/EiJ and P/J 
values. Significant correlations between phenotype and gene expression were only found 
when comparing P/J to AKR/J and RIIIS/J. The greatest r-values (0.624) and lowest 
unadjusted P-values (2.27E-04) were found for Rnf103, Dctn5, and Sod3 transcripts. 
Among the 526 transcripts, a number of them may have a potential role in neonatal 
hyperoxic lung injury based on previously published literature (Table 4.5).  
 QTL genes identified previously (Chapter 3), eQTL genes, and phenotype-
correlated genes were combined and evaluated by IPA to identify potential relatedness 
and function (Table 4.6). Several strongly associated gene networks were identified 
including cell morphology/cellular assembly and organization/cellular development, cell 
death/cardiac necrosis, cellular movement/connective tissue development and 
function/cell morphology, and antigen presentation/cell-to-cell signaling and 
interaction/inflammatory response. Related diseases and disorders include cardiovascular 
disease, genetic disorder, hematological disease, and cancer. Similar networks of 
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associated genes were merged and visualized (Figures 4.6, 4.7). Cellular morphology, 
assembly/organization, development, and death are highly implicated biological functions 
in a network containing caspase, protein kinase B (Akt),  eukaryotic translation initiation 
factor 2α kinase 2 (EIF2AK2), tumor necrosis factor (TNF) receptor, TNF receptor-
associated factor 2 (Traf3), and nuclear factor κB (Figure 4.6). Cell-to-cell signaling and 
interaction, antigen presentation, and inflammatory response were implicated in a 
network including interleukin-12 (IL-12), phosphoinositide-3-kinase (PI3K), interleukin-
1 (IL-1), c-Jun/activator protein 1 (Ap1), low density lipoprotein (LDL), and cAMP 
responsive element binding protein (Creb) (Figure 4.7).  
 Also, dual specificity phosphatase 16 (Dusp16), histocompatibility 2 T region 
locus 10 (H2-T10), and ST3 β-galactosidase α-2,3-sialyltransferase 1 (St3gal1) were 
identified as cis-eQTLs and respective transcript levels were found to correlate with 
epithelial cell counts. There was no overlap in QTL genes identified in Chapter 3 and 
eQTL analysis in baseline expression or transcripts correlating to phenotypic 
characterization of postnatal lungs.  
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Discussion 
 Understanding predisposition and susceptibility to disease has evolved into an 
important component of individualized medicine. Attention has also recently focused on 
susceptibility factors for neonatal lung disease, but knowledge of interaction between 
genetic and environmental factors and the effect on chronic lung disease in the neonatal 
period are minimal (37). The present study applied a genetical genomics approach to 
describe variation in genetics and lung development in neonatal mice to provide insight 
to susceptibility, or genetic predisposition to disease (Figure 4.8). These studies were 
conducted in the mouse, which is an appropriate model organism as the stages of lung 
development are well conserved with slight differences in timing as saccularization is 
completed in the postnatal period (92, 121). 
 Previous studies have characterized expression of specific genes involved in lung 
development and injury including surfactant proteins, antioxidant enzymes, and growth 
factors in a limited number of strains. For example, Bonner et al. (162) and Mariani et al. 
(163) report gene expression profiles in A/J and Swiss Webster lung development from 
organogenesis to maturation. These investigations have provided insight into the 
mechanisms of development and injury, but have not addressed differences that exist in 
lung development that may predispose some populations to injury. In the present study, a 
number of transcript expression profiles with biological importance were identified by 
comparing basal transcript expression in lungs from 30 strains of inbred mice at postnatal 
day 4. Some gene transcripts that were differentially expressed, including fibroblast 
growth factor 7 or keratinocyte growth factor (Fgf7), connective tissue growth factor 
(Ctgf), eosinophil-associated ribonuclease (Ear) genes, and a disintegrin-like and 
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metallopeptidase with thrombospondin (Adamts) genes, were also identified in previous 
investigations (162, 163). Because these genes are involved in lung development and 
have variation in expression across strains, they may be considered potential targets for 
further investigation in determining predisposition or susceptibility to neonatal 
respiratory disorders. 
Fgf7 and Ctgf have been implicated in lung development and BPD in humans and 
experimental models. Fgf7 stimulates surfactant protein synthesis in prenatal rats and 
decreases mortality of hyperoxia-exposed neonatal mice (164, 165). Increased fibroblast 
growth factor 7 in BALF in low birth weight infants has also been associated with 
reduced BPD (166). Interestingly, Apoa2 is another gene that was differentially expressed 
across strains and has also been linked to surfactant protein synthesis in humans (167). 
Ctgf is involved in tissue development and remodeling, and increased expression and 
secretion have been found in animal models of hyperoxic lung injury and mechanical 
ventilation in neonates. Upregulation of Ctgf has been suggested to contribute to 
disrupted alveolarization and vascular development (168, 169). Furthermore, neutralizing 
CTGF antibodies protect against bleomycin- and radiation-induced lung injury and in 
neonatal animal models of hyperoxia-induced lung injury (168). In the present study, Ctgf 
was differentially expressed (FC = 2.43) and correlated with epithelial cell injury in our 
model of neonatal hyperoxic lung injury described in Chapters 2 and 3.   
 Several other genes with basal expression levels that correlated with epithelial cell 
injury across inbred strains of mice have biological plausibility. For example, Sod3 
(superoxide dismutase 3) is of interest because it protects against oxidant injury caused 
by neonatal hyperoxia exposure (89). Angpt2 (angiopoieten2) and Eng (endoglin) are 
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involved in vascularization and these genes are modulated by hyperoxia and mechanical 
ventilation in humans and mouse models (94, 170). Mylk (myosin light chain kinase, non-
muscle) has been implicated in endothelial barrier function, neutrophil migration, acute 
lung injury, and recent evidence suggests modulation by hyperoxia exposure (171-174).  
 In addition to correlation analysis, eQTL analysis also was informative on genetic 
and genomic variation in postnatal gene expression in the lung across inbred mice. A 
disintegrin and metalloproteinase 17 (Adam17) and Tnfα-induced protein 2 (Tnfaip2) are 
potentially important to predisposition of neonatal lung injury as they are associated with 
the pro-inflammatory TNF pathway. A precise role of Tnfaip2 has not been described, 
but evidence suggests it is an angiogenic factor and can promote cell migration (175). 
Adam17 has recently been implicated as an important regulator of the acute inflammatory 
response. For example, in a model of endotoxin-induced acute lung injury, Dreymueller 
et al. (176) found that Adam17 is required for endothelial permeability, neutrophil 
migration, and Tnf and IL-6 production. Furthermore, Adam17 can be activated by IL-1 
and MAPK, which have been described in neonatal lung injury (177, 178). Eif2ak2 also 
contains a noteworthy eQTL identified in the postnatal lung, as it is a hyperoxia-induced 
transcription factor and has a central role in the integrated stress response in the newborn 
rat lung (179).  
 In addition to biologically plausible gene candidates identified by cluster and 
correlation analyses, potential insight to inter-strain variation in lung development and 
response to hyperoxic lung injury may be gained from integration of gene discovery 
approaches. IPA was used to identify physiological functions or gene networks that may 
contribute to variation in lung development and susceptibility. After combining gene lists 
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from QTL, eQTL, and correlation analysis, IPA identified networks between several 
inflammation and immunity genes including Traf3, Traf6, Tnip1, Adam17, Nfrkb, and 
Tnfaip (Figure 4.6). NfκB and Tnf have central roles in this network, and have been 
previously linked to BPD (6, 31, 180). Although NfkB and Tnf were not differentially 
expressed between strains, these pathways may still be important to susceptibility to 
hyperoxic lung injury as the causal variants may exist in other genes (94, 181). Similarly, 
another network implicated variation in Il-12, Il-1, PI3K, and Ap1 signaling in postnatal 
lung development. Interestingly, both IL-1 and IL-12 have been described as potential 
biomarkers of perinatal lung complications and lung injury (114, 177). These examples of 
integrated gene network analysis illustrate the potential to provide important insight into 
pathways that may contribute to inter-strain variation in lung development and 
susceptibility to lung injury.  
 It is also important to consider the limitations of the data presented in this study. 
Pathway analyses are not by themselves evidence of mechanisms, but provide a means to 
prioritize large gene lists like those generated in this investigation for further 
investigation. Another limitation of the investigation is that expression profiles and 
networks were derived for whole lung homogenates which are expected to be influenced 
by various dynamic cell populations. Ideally, gene expression for single cell types such as 
alveolar macrophages or alveolar type I or II cells would enable more clear interpretation 
of cell-specific processes. The present study describes variation in the lung with all of its 
physiological components, and may nevertheless yield important information regarding 
differences in cell-cell interaction across multiple strains that could not be obtained by 
examination of single cell types. Furthermore, the kinetics of gene expression from P1-P4 
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provides cross-sectional integrated evaluation of postnatal lung development which may 
have important implications for understanding inter-strain variation in response to 
postnatal environmental stimuli. Finally, analysis of the e-QTL trans-bands would 
provide additional insight to mechanistic underpinnings of genes that are differentially 
expressed at postnatal day 4. For example, a study conducted by Wu et al. (182) 
identified a cyclin H as a trans-eQTL in adipose tissue. Further functional enrichment 
analysis of the genes having transcript association with cyclin H genotype revealed a role 
of cyclin H in regulating oxidative phosphorylation. Future studies will identify trans-
eQTLs and generate mechanistic hypotheses to be evaluated in postnatal lung 
development.  
In summary, the genetic and genomic data compiled in this study regarding 
postnatal lung development will be invaluable in identifying genetic factors that 
contribute to understanding susceptibility to neonatal lung disease. This information can 
be applied not only to susceptibility to hyperoxic lung injury, but also other neonatal and 
adult lung diseases, the latter of which probes fetal origins of adult disease.  
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Figure 4. 1 Relatedness of inbred strains of mice. Inbred mice are divided into 7 
groups based on evolutionary relationships. Group 1: Bagg albino derivatives; Group 2: 
Swiss mice; Group 3: Japanese and New Zealand mice; Group 4: C57 and C58 strains; 
Group 5: Castle’s mice; Group 6: Little’s DBA and related strains; Group 7: wild-derived 
strains. Strains underlined in blue were used for genomic analysis of hyperoxic lung 
injury in neonatal mice. Adapted from Petkov et al. Genome Research 14 (2004). 
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Figure 4. 2 Profiles of hyperoxia-induced differential gene expression. A. Gene 
expression profiles in lungs from 30 strains of inbred mice are shown for transcripts that 
have a fold change greater than 1.5 in at least two strains at postnatal day 4. Transcript 
levels are shown as quantile normalized and Log2 transformed mean intensities 
(n=3/strain) B. Expression profiles are shown for the transcripts with the greatest fold 
change.  
A. 
 
B. 
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Figure 4. 3 Differential gene expression profiles in hyperoxia-resistant and 
susceptible strains of mice on postnatal days 1-4. Profiles include transcript intensity 
values normalized to strain-matched expression at P1 having differential gene expression 
between resistant (129S1/SvImJ and BALB/cByJ) and susceptible strains (C3H/HeJ and 
C57BL/6J). 
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Figure 4. 4 Differentially expressed genes in hyperoxia-resistant and susceptible 
strains of mice on postnatal days 1-4. The venn diagram and table shows the overlap of 
genes with differential expression between resistant (129S1/SvImJ and BALB/cByJ) and 
susceptible strains (C3H/HeJ and C57BL/6J) on each day.  
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Figure 4. 5 Genome-wide eQTL analysis.  A. All significant haplotype-transcript 
associations (p < 0.05) in lungs at postnatal day 4 are shown by global location. Cis-
regulated eQTL genes are located at the diagonal line and all other associations are trans-
regulated genes. B. The mean intensities of a Tnfaip2 transcript across 30 strains of 
inbred mice are shown as a strain distribution patter. C. Haplotype association mapping 
with the Tnfaip2 transcript intensity shows seven significant QTLs. A cis-eQTL is 
highlighted on chromosome 12. D. All eQTLs for the Tnfaip2 transcript are shown. The 
cis-eQTL falls on the diagonal line and the other eQTLs are trans-acting.  
A. 
 
B. 
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C. 
 
D. 
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Figure 4. 6 IPA network of cell morphology and death, cellular assembly, 
organization, and development, and cardiac necrosis. This network of genes 
represents direct and indirect relationships between genes identified in QTL, eQTL, and 
correlation analysis with genetical genomic analysis in postnatal gene expression in the 
lung and hyperoxic lung injury phenotypes. The first and second networks in Table 4.5, 
having scores of 47 and 36, were merged and new relationships are represented in orange. 
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Figure 4. 7 IPA network of cellular movement, connective tissue development and 
function, cell morphology and death, and cell-to-cell signaling and interaction.  This 
network of genes represents direct and indirect relationships between genes identified in 
QTL, eQTL, and correlation analysis in postnatal gene expression in the lung and 
hyperoxic lung injury phenotypes. The third and fourth networks in Table 4.5, both 
having scores of 31, were merged and new relationships are represented in orange. 
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Figure 4. 8 Schematic of genetical genomics. QTLs are associations between genomic 
loci (SNPs or haplotype) and disease phenotypes. eQTLs are associations between 
genomic loci (SNPs or haplotype) and expression levels of gene transcripts. The 
relationship between genomic loci and disease or phenotype is often complex, linked 
through a network of gene-gene (and gene-environment) interactions. 
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Table 4.1Variation in gene expression at postnatal day 4 in 30 strains of mice. Fold 
change ranges are shown for genes that were differentially expressed in lungs in at least 
two strains and the number of genes in each range is given. Fold change is based on Log2 
transformed probe intensities.  
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Table 4.2 Differentially expressed genes in the lung at postnatal day 4. Transcripts 
and respective genes having a fold change greater than 6.0 are shown with the 
corresponding Entrez gene ID, accession number, and chromosome.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fold change Symbol Gene name Entrez Gene ID Accession Probe ID Chromosome
7.80              
7.74 Actb Actin, beta 11461 NM_007393.1
ILMN_2588055   
ILMN_2846865 5
7.38              
6.55 Lyz1 Lysozyme 1 17110 NM_013590.3
ILMN_2736867 
ILMN_1247933 10
7.29 Ahsg Alph-2-HS-glycoprotein 11625 NM_013465.1 ILMN_2764036 16
6.87 MT-ND1 NADH dehydrogenase 1 ILMN_2483935
6.72 Serpina1b Serbina 1B peptidase inhibitor 20701 NM_009244.4 ILMN_2659680 12
6.67 MT-ATP6 ATP synthase 6 ILMN_2504686
6.43 Apoa2 Apolipoprotein A-2 11807 NM_013474.1 ILMN_1247156 1
6.23 S100a8 S100 calcium binding protein A8 20201 NM_013650.2 ILMN_2710905 3
6.16 Apoa1 Apolipoprotein A-I 11806 NM_009692.2 ILMN_2623393 9
6.12 Myl1 Myosin, light polypeptide 1 17901 NM_021285.1 ILMN_2878542 1
6.09 Csrp1 Cysteine and glycine-rich protein 1 13007 NM_007791.4 ILMN_1260378 1
6.04 Kng1 Kininogen 1 16644 NM_023125.2 ILMN_2788223 16
6.01 Ear2 Eosinophil-associated, ribonuclease A family, member 2 13587 NM_007895.2 ILMN_2731735 14
6.00 Ttr Transthyretin 22139 NM_013697.3 ILMN_2443330 18
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Table 4.3 IPA networks and physiological functions associated with differentially 
expressed genes in hyperoxia-resistant and susceptible mice. Ingenuity pathway 
analysis was done using genes differentially expressed in lung between hyperoxia-
resistant (129S1/SvImJ and BALB/cByJ) and sensitive (C3H/HeJ and C57BL/6J) mice at 
postnatal day 1, 2, 3, and 4. Genes differentially expressed on each day were also 
combined for analysis.  
 
 
 
Associated Network Functions Score
Cellular growth and proliferation, hematological system development and function, humoral immune response 44
Energy production, molecular transport, nucleic acid metabolism 35
Organ morphology, cancer 35
Carbohydrate metabolism, small molecule biochemistry 34
Cellular movement, cell morphology, infection mechanism 33
Physiological System Development and Function # Genes
Hematological system development and function 70
Immune cell trafficking 34
Tissue morphology 64
Associated Network Functions Score
Antigen presentation, cell-to-cell signaling and interaction, hematological system development and function 38
Infection mechanism, infectious disease, cellular movement 31
Hematological system development and function, immune cell trafficking, inflammatory response 27
Cancer, cellular growth and proliferation, respiratory disease 26
Cell-to-cell signaling and interaction, tissue development 25
Physiological System Development and Function # Genes
Hematological system development and function 74
Tissue morphology 50
Immune cell trafficking 48
Cell-mediated immune response 33
Hematopoiesis 44
POSTNATAL DAY 1
POSTNATAL DAY 2
95 
 
Table 4.3 continued.
 
 
 
 
Associated Network Functions Score
Cellular growth and proliferation, cell cycle, cancer 48
Molecular transport, small molecule biochemistry, cellular development 32
Connective tissue disorders, organismal injury and abnormalities, cardiovascular system development and function 26
Connective tissue disorders, genetic disorder, dermatological disease and conditions 25
Developmental disorder 25
Physiological System Development and Function # Genes
Embryonic development 17
Cardiovascular system development and function 15
Organismal development 8
Associated Network Functions Score
Cellular compromise, DNA replication, recombination, and repair, cell-to-cell signaling and interaction 32
Cellular development, cellular growth and proliferation, tumor morphology 29
Cell death, cell cycle, cellular growth and prolfieration 19
Tumor morphology, cell cycle, immunological disease 16
Physiological System Development and Function # Genes
Connective tissue development and function 4
Cardiovascular system development and function 4
Embryonic development 3
Associated Network Functions Score
Gene expression, cell-to-cell signaling and interaction, hematological system development and function 37
Cellular compromise, DNA replication, recombination, and repair, cell-to-cell signaling and interaction 33
Physiological System Development and Function # Genes
Connective tissue development and function 3
Cardiovascular system development and function 3
Embryonic development 4
Organismal development 4
POSTNATAL DAY 3
POSTNATAL DAY 4
POSTNATAL DAYS 1-4
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Table 4.4 Genome-wide cis-eQTLs in murine lungs at postnatal day 4. Genomic loci 
(SNPs) that significantly associate with expression of transcript probes within 1 
megabase were identified as cis-eQTLs. Analysis was done using lungs from 30 strains of 
inbred mice at postnatal day 4. 
 
 
 
 
 
 
 
 
Gene Symbol Gene name P -value SNP Global Location Probe Global Location Chromosome
Adamdec1 ADAM-like, decysin 1 5.00E-04 1967141510 1967128250 14
Lars2 Leucyl-tRNA synthetase, mitochondrial 5.00E-04 1403838234 1403862551 9
Samd4 Sterile alpha motif domain containting 4 5.00E-04 1945665721 1945667878 14
Lypd6 LY6/PLAUR domain containing 6 2.00E-03 247198482 247244276 2
Adam17 ADAM metallopeptidase domain 17 5.00E-03 1677764025 1677735267 12
Hps5 Hermansky-Pudlak syndrome 5 5.00E-03 1050246015 1050243634 7
Rpe Ribulose-5-phosphate-3-epimerase 7.00E-03 66755912 66766221 1
Slc25a3 Mitochondrial-phosphate carrier 9.00E-03 1495148621 1495113792 10
Dusp16 Dual specificity phophatase 16 1.00E-02 981396540 981376381 6
St7l Suppression of tumorigenicity 7 like 1.40E-02 483642727 483673077 3
H2-T10 Histocompatibility 2, T region locus 10 1.90E-02 2261131441 2261212913 17
Rbbp4 Retinoblastoma binding protein 2.60E-02 667546261 667529831 4
Prdx1 Peroxiredoxin 1 2.80E-02 654914305 654740994 4
Eif2ak2 Eukaryotic translation initiation factor 2-alpha kinase 2 3.20E-02 2304221448 2304207249 17
Adam23 ADAM metallopeptidase domain 23 3.60E-02 63538291 63640153 1
Cftr Cystic fibrosis transmembrane conductance regulator 3.80E-02 864869878 864932344 6
Enpp5 Ectonucleotide pyrophosphodiesterase 5 7.80E-02 2269177587 2269178567 17
St3gal1 ST3 beta-galactoside alpha-2,3-sialytransferase 1 9.50E-02 2090083879 2090079105 15
Myh14 Myosin, heavy chain 14 1.18E-01 1048092362 1048089108 7
Tnfaip2 Tumor necrosis factor, alpha-induced protein 2 1.42E-01 1769094477 1769097464 12
Diap3 Diaphanous homolog 3 1.48E-01 1984990389 1985002548 14
Olfml1 Olfactomedin-like 1 1.66E-01 1110946568 1110962229 7
Ppa2 Pyrophosphatase 2 1.83E-01 511939069 511945751 3
Cap1 Adenylate cyclase-associated protein 1 1.85E-01 661093991 661079807 4
Capn2 Calpain 2 1.99E-01 184409395 184309257 1
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Table 4.5 Genes correlated with hyperoxia-induced BALF epithelial cell counts in 30 
strains of inbred mice. A linear regression model was used to determine the correlation 
(r) and unadjusted P-value between transcript probe intensities and BALF epithelial cell 
counts obtained after 72 hours hyperoxia exposure.  
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Table 4.6  IPA networks and physiological functions associated with differentially 
expressed genes in postnatal lungs from 30 strains of mice. Ingenuity pathway 
analysis was used to characterize the associated networks and physiological functions in 
genes identified in QTL, cis-eQTL, and correlation analysis in postnatal gene expression 
in the lung and hyperoxic lung injury phenotypes.  
 
 
 
 
 
 
 
 
  
Associated Network Functions Score
Cell morphology, cellular assembly and organization, cellular development 47
Cell death, cardiac necrosis/cell death 36
Cellular movement, connective tissue development and function, cell morphology 31
Cell morphology, cell-to-cell signaling and interaction, cell death 31
Antigen presentation, cell-to-cell signaling and interaction, inflammatory response 20
Physiological System Development and Function # Genes
Embryonic development 19
Tissue morphology 20
Connective tissue development and function 13
Hematological system development and function 20
POSTNATAL LUNG DEVELOPMENT
 
 
CHAPTER 5 
 
INTER-STRAIN VARIATION IN HYPEROXIA-INDUCED POSTNATAL LUNG 
GENE EXPRESSION IN INBRED MICE 
 
Introduction 
Genome-wide association studies (GWAS) have been used to identify functional 
genetic variants that underlie disease susceptibility (154). Despite the popularity of 
GWAS in human disease, few advances in understanding the genetic contribution to 
disease have been made (155, 156). Animal models have been utilized to circumvent the 
challenges of GWAS using human cohorts including population stratification, variable 
environmental factors, and limitations on experimental validation (94, 95, 154, 157). 
However, it can also be challenging to identify genetic factors contributing to disease in 
animal models of GWAS (haplotype association mapping), most often the mouse, as 
QTLs often contain a large number of genes, making it difficult to identify the causative 
SNP (158, 159). Furthermore, the relevance of the causative SNP to the disease 
phenotype is frequently not understood (156).  
Integrating genetics and genomics in expression QTL (eQTL) analysis provides 
an additional tool in evaluating how genetic variation at a genomic locus can associate 
with a disease or phenotype by modifying transcript levels within gene networks (160). 
Furthermore, relationships identified between gene networks and disease phenotypes can 
broaden our understanding of disease mechanisms and susceptibility (161). This concept 
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was demonstrated in Chapter 4 as inter-strain genetic and genomic variation in postnatal 
lungs was described. Several susceptibility gene candidates were identified by a 
combined approach including cis-eQTL analysis and correlation analysis of transcript 
levels and disease phenotypes. Characterization of these genes implicated variation in 
gene networks and signaling pathways that had not been previously described.  
Similarly, the present chapter applies an integrated genetics and genomics 
approach to understand how genetic variation in neonatal inbred mice associates with 
response to hyperoxia exposure and oxidant lung injury. Chapter 2 previously described a 
model of hyperoxic lung injury in neonatal mice that mimics BPD phenotypes, and 
Chapter 3 identified Chrm2 as a candidate susceptibility gene. However, given the 
complex nature of the hyperoxic lung injury phenotypes, a single gene cannot account for 
the phenotypic variation. Consequently, additional genes need to be elucidated to better 
understand susceptibility to neonatal hyperoxic lung injury.  
Furthermore, decades of research on BPD and animal models of BPD, including 
hyperoxic lung injury, have described a number of genes in disease pathogenesis 
including surfactant proteins, growth factors, cytokines, antioxidant defenses, 
metalloproteinases, and transcription factors (6, 35, 36, 94). Despite these advances, BPD 
incidence has not decreased in preterm infants and a critical need to understand variation 
in genes involved in inflammation and injury is recognized (90). This study was designed 
to provide additional and novel insight into genetic factors and mechanisms that 
contribute to oxidant injury in the postnatal lung.  
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Methods 
Animals 
Male and female mice (4-10 weeks) from 30 inbred strains were obtained for study (The 
Jackson Laboratory, Bar Harbor, ME). Strains were chosen to maximize genetic diversity 
(Figure 5.1). Upon arrival, animals were caged individually, maintained in a 12:12 
light:dark cycle at 72°F with 50% humidity, and provided food and water ad libitum. 
Mice acclimated to these conditions for at least a week prior to mating. Males and 
females were housed together for 3-5 days. Following mating, males were removed and 
1-3 females were housed per cage until pregnancy was confirmed. After spontaneous 
birth, the pups were cross-fostered with Swiss Webster dams (Charles River, 
Wilmington, MA) to ensure adequate and consistent maternal care. Litters with foster 
dams were maintained in a chamber supplied with ≥ 95% oxygen (UHP grade, min. 
purity 99.994%, National Welders, Durham, NC) for 72 hours. The chamber was opened 
for approximately 30 min each morning for health checks and cage cleaning. Foster dams 
were also replaced at this time to avoid changes in maternal care due to hyperoxia effects 
to the dam. After termination of exposure, mice were weighed and anesthetized by i.p. 
injection of sodium pentobarbital (104 mg/kg) Lungs were removed and homogenized 
before snap freezing. All animal use was approved by the NIEHS Animal Care and Use 
Committee 
 
RNA isolation 
 Whole lungs were collected in triplicate in all cases and snap frozen as described 
above and stored at -80°C until processed. RNA was extracted from approximately 20 
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mg of frozen lung tissue using the RNeasy Plus Kit, the Tissuelyser LT, and the QIAcube 
according to the manufacturer’s protocol (Qiagen, Valencia, CA). RNA quality was 
verified (A260/A280 > 1.8) and provided to the NIEHS Microarray Core (NMC). 
 
Illumina genechip analysis 
Microarray hybridization was conducted in the NMC with lung homogenates 
from 30 strains of mice (Figure 5.1) exposed to hyperoxia for 72 hours using Illumina 
Sentrix Beadchip Mouse WG-6 v2 arrays (Illumina, Inc., San Diego, CA) following the 
Illumina Whole-Genome Gene Expression Direct Hybridization Assay Guide. Starting 
with 250 ng of total RNA, biotin labeled cRNA was produced according to Ambion’s 
Illumina TotalPrep RNA Amplification Kit protocol. For each sample, 1.5 µg of biotin 
labeled cRNA was hybridized for 17 hrs in a static hybridization oven. Slides were 
washed and stained with streptavidin-Cy3 according to Illumina’s protocol and then 
scanned with an Illumina BeadArray Reader with BeadScan software (version 3). Probe 
hybridization intensity ata were obtained using Illumina GenomeStudio software 
(V2011.1), Resolver® system (version 7.1) (Rosetta Biosoftware, Kirkland, WA). 
Initial quality control performed in the NMC utilized principal components 
analysis (PCA) on all samples and all probes to characterize the variability present in the 
data. A batch effect was identified in arrays manufactured in different facilities and was 
minimized by randomizing the samples run on each set of arrays. To further evaluate the 
batch effect present in the data, we collaborated with the Microarray and Genome 
Informatics (MGI) group at NIEHS (Pierre Bushel and Jun Lu, personal communication) 
to employ normalization and batch correction strategies. The raw expression data were 
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quantile normalized (probe ranked by their expression) within replicates and scaled by 
median (to 150) across all samples. The batch correction was then performed on the Log2 
transformed normalized data, based on the following analysis of variance (ANOVA) 
model: 
 
Yijkl = µ + αi + βj + (αβ)ij + Yk + εijkl, for i = 1,…,30, j = 1,2, k = 1,2 and l = 1,2,3 
 
The parameters αi correspond to the effects of the strains, the βj corresponds to the 
treatment effects, the parameters (αβ)ij are the interaction of the strain by treatment, and 
the parameters Yk correspond to the batch effects. The estimated batch effects Yk were 
then removed from the observed expression values Yijkl to obtain the normalized and 
batch corrected data. 
 
e-QTL analysis 
The Illumina raw intensity values were normalized by Log2 transformation prior 
to eQTL analysis in FastMap. eQTL analysis was similar to the HAM described in 
Chapter 3, where the array probes were used as quantitative phenotypes. Briefly, an 
ANOVA was conducted to determine strength of genetic association between the 
normalized probe intensities and the haplotype structure. For each transcript, FastMap 
first generates a P-value for the association between the normalized probe intensities and 
each 3-SNP window by performing an ANOVA.  These P-values are used to calculate 
association scores, which are –Log10P.  Subsequently, FastMap performs a permutation 
test to correct for multiple comparisons. This was done by randomizing the normalized 
probe intensities across the strains and recalculating the association scores, then storing 
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the maximum value. This was repeated 1000 times, and a corrected P-value is assigned to 
each association score based on the proportion of permuted scores that are greater (i.e. if 
20% of the 1000 tests produce an association score that is higher than the actual score, 
the assigned P-value is 0.2). P-value thresholds were set at 0.05 for significant, 0.2 for 
highly suggestive, and 0.5 for suggestive. cis-eQTLs are those in which a strong 
association exists between the expression of a gene and the locally inferred haplotype and 
were limited to a one megabase (Mb) window centered on the location of the respective 
SNP.  
 
Correlation analysis of gene expression and hyperoxic lung injury phenotypes 
To determine significant correlations between transcript levels and hyperoxic lung 
injury phenotypes (Chapter 2), a linear regression model was developed by (MGI group, 
personal communication). The Log2 transformed normalized and batch corrected Illumina 
expression data were acquired as described above. Quantitative phenotype measurements 
(Chapter 2), with the exception of BALF protein, were Log2 transformed prior to 
analysis. To determine the strength of correlation between probes and phenotypes, each 
gene expression chip (1 per animal, 3 animals per strain) was matched to 5 phenotypic 
measurements drawn (i.e. sampled) from a normal distribution where the mean and 
standard deviations were estimated from the observed data. It is assumed that the 
populations are normally distributed and that 1) the population variances are equal 2) the 
data are independent random samples and 3) the random errors follow a normal 
distribution. A linear model was then used to regress each phenotypic measurement on 
the gene expression measured by each probe for the comparison of either a high 
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responder (maximum phenotypic mean value) strain or a low responder (minimum 
phenotypic mean value) strain with all other strains. Correlations (between the gene 
expression measured by probes and the sampled phenotype measurements) having a 
nominal P-value at or below 0.0005 were considered less likely to be due to chance.  
 
Gene ontology and pathway analysis 
 Ingenuity pathway analysis (IPA) (Redwood City, CA) and the Database for 
Annotation, Visualization, and Integrated Discovery (DAVID, david.abcc.ncifcrf.gov) 
were used to determine gene networks, gene ontology, canonical signalling pathways, 
and physiological functions associated with gene lists compiled by various gene 
expression analyses in postnatal lungs exposed to hyperoxia for 72 hours.  
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Results 
Variation in gene expression between strains 
We identified 5,386 transcripts that had an absolute fold change (FC) greater than 
1.5 and considered to be differentially expressed in at least two strains after 72 hr 
exposure to 100% O2 (Figure 5.2, Supplemental Table 5.1). Most transcript probes had a 
FC between 1.5 and 2 when comparing the lowest and highest intensities for each probe 
across all strains (n = 2,545). There were 19 probes found to have a FC above 5.5 
including S100A8, Lyz1, Actb, Myl1, Stfa1, Krt13, Mylpf, Nppa, Gapdh, Isca1, Tmem14c, 
H2-D1, Ear2, Tnnc2, Scgb3a1, Ahsg, Acta1, Myh8, and Mgst1 (Table 5.2).  
Many of the genes (n = 2940) differentially expressed in neonatal lungs across 
strains following hyperoxia exposure were also differentially expressed at baseline; 
however, 1,230 genes were found to have a FC greater than 1.5 in at least two strains 
only after hyperoxia exposure (Figure 5.3, Supplemental Table 5.2). Gene ontology and 
pathway analysis using the DAVID functional annotation database found these unique 
hyperoxia-induced genes to be involved in cellular, metabolic, and developmental 
processes, as well as organization and localization (Table 5.3). Furthermore, these genes 
are associated with a number of pathways such as chemokine and toll-like receptor 
signaling, leukocyte transendothelial migration, and cell adhesion (Table 5.3).  
 
cis-eQTL analysis of differentially expressed genes following hyperoxia exposure 
eQTL analysis was then used to identify statistically significant associations 
between hyperoxia-induced differentially expressed transcripts and SNPs mapped in the 
murine genome (Figure 5.4A). These eQTLs were then queried for those considered to be 
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cis acting, or having an association between the expression of a transcript and the 
respective gene’s locally inferred haplotype, which appear as a diagonal line when the 
probe location is plotted against the SNP location. A representative example of the cis-
eQTLs was found for Trim30, which is located on chromosome 7 (Figure 5.4B). Other 
genes with cis-eQTLs include Cftr, H2-Aa, Rusc2, Hc, Thap4, Insig2, Cap1, Ifi47, 
Cldn12, Slc12a2, Samd4, Capn2, Fxc1, Sc4mol, Ccdc53, Atrnl1, Daam1, Vcp, Atp10d, 
Pkm2, and Usp25 (Table 5.5).  
 
Correlation of gene expression at postnatal day 4 with hyperoxic lung injury phenotypes 
 A linear regression model was used to determine correlation between transcript 
levels and lung injury phenotypes following hyperoxia exposure. Pairwise comparisons 
between probe intensities and phenotypes were made for low and high responding strains 
against all other strains. No significant correlations were found after comparing transcript 
levels against low and high responding strains for BALF protein (BALB/cByJ and 
C3H/HeJ) and mean numbers of BALF macrophages (Molf/EiJ and 129S1/SvImJ). 
However, Klk11 was negatively correlated (r = -0.65, unadjusted p = .0001) and Tmco4 
was positively correlated (r = 0.65, unadjusted p = .0001) with mean numbers of 
epithelial cells.  
 SWR/J and PWK/PhJ strains were used as the low and high responding strains, 
respectively, to which transcripts and hyperoxia-induced numbers of neutrophils across 
all other strains were compared. 1,107 significant correlations were found, yielding 218 
unique genes. Significant correlations were found only when SWR/J and PWK/PhJ 
transcripts and neutrophils were compared to KK/HiJ. The transcripts with the strongest 
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positive correlation were Ensa and Nrcam (r = 0.687, unadjusted P = 2.67E-05) while the 
transcripts with the strongest negative correlation were S1pr3 and Hgsnat (r = -0.685, 
unadjusted P = 2.88 E-05). Among the 218 genes, a number of them have biological 
plausibility in mechanisms of hyperoxic lung injury (Table 5.6).  
 
Gene network analyses 
 IPA was used to evaluate the relatedness and functions of genes identified by 
QTL analysis (Chapter 3), cis-eQTL analysis of hyperoxia-induced transcripts, and 
phenotype-transcript correlation analysis. Several strongly associated gene networks were 
identified including cell death/antigen presentation/cellular movement and carbohydrate 
metabolism/small molecule biochemistry/cellular movement (Table 5.6). These networks 
have a number of central molecules including p38 mitogen-activated protein kinase 
(MAPK), extracellular regulated MAP kinase (ERK), Ras, and vascular endothelial 
growth factor (VEGF) (Figure 5.5). Cell death/cellular development/cell morphology, 
and molecular transport/cellular function and maintenance networks were also related to 
QTL, eQTL, and phenotype correlated genes and contain interleukin-12 (IL-12), 
interferon regulatory factor 2 (IRF2), nuclear factor κB (NFκB), and c-Jun/activator 
protein 1 (Ap1) as central molecules (Figure 5.6). Physiological functions associated with 
the comprehensive gene list include organismal development, cardiovascular and 
hematological system development and function, immune cell trafficking and tissue 
development (Table 5.7).  
 Analysis of these genes with DAVID identified associated canonical signaling 
pathways including apoptosis, toll-like receptor signaling, and MAPK signaling. Il1, 
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Fadd, Fas, Apaf1, Cap9, Nfkb, Traf6, Fgf, Pdgf, and Creb were genes identified in the 
genetic and genomic analyses that function in these pathways.  
 Overall, overlap was found between genes identified by hyperoxic lung injury 
QTL analysis and cis-eQTL analysis and transcript expression levels that correlated with 
hyperoxic lung injury phenotypes. Mgmt and Foxa2, identified by QTL analysis, and H2-
Aa, Cldn12, Slc12a2, Sc4mol,Casp9, and Ccdc53, identified by cis-eQTL analysis also 
correlated with BALF neutrophils.  
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Discussion 
 The objective of this study was to use an integrated genetic and genomic approach 
to describe inter-strain variation in response to postnatal hyperoxic lung injury, and 
identify candidate susceptibility genes and gene networks. While the previous chapter 
queried whether inter-strain variation in basal gene transcript expression predisposed the 
lung to hyperoxic injury, the genetic and genomic analysis of this chapter was designed 
to identify genetic factors that modulate the response to hyperoxia exposure.  
 The biological processes “inflammation” and “cell survival and death” were most 
significantly implicated by the genetics and genomics approach used in the present study 
to understand mechanisms of hyperoxic lung injury. Examination of genes from neonatal 
lungs that have differential expression and genes that were correlated with hyperoxia-
induced changes in neutrophils after hyperoxia exposure suggests involvement of several 
known pathways including chemokine signaling, leukocyte migration, transforming 
growth factor β (TGFβ) signaling, p53 and apoptosis, toll-like receptor signaling, 
mitogen activated protein kinase (MAPK) signaling, and ubiquitin mediated proteolysis. 
Most of these pathways were previously implicated in hyperoxic lung injury or 
bronchopulmonary dysplasia (31, 35, 112, 183, 184), which reinforces the potential 
relevance of the genes identified in this analysis. 
 In particular, a number of genes were identified that participate in TGFβ 
signaling, which has been previously described in postnatal lung development and injury 
and bronchopulmonary dysplasia (185). Thrombospondin-3, leukotriene B4 receptor, and 
bone morphogenic protein 2 expression levels correlated with the neutrophilic response 
to hyperoxia and are capable of binding to and increasing TGFβ transcription (185-187). 
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Furthermore, Smad2 and Smad3 were also identified by correlation analysis, and are 
required for TGFβ transcription, which among many targets includes interleukin-16 
(IL16) and Foxa2 (187, 188). IL-16 is a potent chemoattractant that has not been 
previously described in hyperoxic lung injury, but significantly correlated with 
hyperoxia-induced neutrophilia. Foxa2, a candidate gene found in QTL analysis with the 
neutrophil phenotype, is important in epithelial cell fate during lung development; 
however, its expression is sufficient to induce Th2 mediated inflammation and may be 
involved in predisposition to chronic lung disease (188). While TGFβ signaling is critical 
for normal lung development, diminished or enhanced signaling adversely affects lung 
development and further investigation may explain differential response to oxidant stress.  
 Mgmt, O-6-methylguanine-DNA methyltransferase, was described in Chapter 3 as 
a candidate susceptibility gene identified by HAM with the macrophage phenotype. 
Interestingly, Mgmt also correlated with hyperoxia-induced neutrophilia. MGMT is the 
only cellular defense against O-6-methylguanine DNA adducts and it functions by 
extracting the alkyl group to form S-methyl-L-cysteine, which subsequently, is rapidly 
degraded (189). While deficiencies in Mgmt predispose a cell to death upon DNA 
alkyation (methylation), adverse consequences are also reported when S-methyl-L-
cysteine is not degraded, indicating that Mgmt function must be carefully regulated. Most 
studies of Mgmt have been conducted using in vivo and in vitro models of exposure to 
alkylating agents, and evidence of hyperoxia-induced DNA methylation is limited (190, 
191). Nevertheless, the present HAM and expression studies warrant future investigation 
of this gene candidate in the hyperoxia model. 
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 The most recurrent biological functions and canonical pathways identified in the 
baseline and hyperoxia-induced genetic and genomic analyses are “apoptosis” and 
“inflammation through MAPK and NFκB signaling”. These pathways are highly 
interactive (see Figures 5.5-5.8) and are dependent upon or involve a number of genes 
that have been associated with hyperoxic lung injury. For example, NFκB can be induced 
by CD44, S100 calcium binding protein A8 (S100a8), and Tnf receptor-associated factor 
6 (Traf6) and it is known to activate transcription of a number of genes including Il1, 
Il15ra, Ccl2, Ccr5, and Cd44. IL-1 can, in turn, activate the apoptotic pathway through 
Fas-associated death domain (Fadd) and apoptotic peptidase activating factor 1 (Apaf1) 
signaling, leading to initiation of the caspase cascade through caspase 9 activation. IL-1 
can also trigger the MAPK cascade (Figure 5.9), as well as fibroblast growth factor (Fgf) 
and platelet-derived growth factor (Pdgf), which involves Ras, MAP kinase-specific 
phosphatase (MKP), growth arrest and DNA damage induced gene (GADD), and Creb. 
While the overlap is apparent, it is also indicative of a vast gene network linked to 
hyperoxic lung injury phenotypes. 
 eQTL analysis provided an important tool to query the association between 
transcript expression and genetic variation in these complex networks. It is noteworthy 
that a hyperoxia-responsive cis-eQTL was identified in Casp9, as apoptosis and caspase 9 
were implicated by the genomic analysis of hyperoxic lung injury as previously described 
(Figure 5.7). Another cis-eQTL was found in Vcp, a gene that encodes valosin containing 
protein (also known as p97 and Cdc48) which is a highly conserved ATPase with a 
central function in ubiquitin-dependent proteolysis or the unfolded protein response 
(UPR) (192). Mutations in VCP have been described in the pathogenesis of a number of 
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neurodegenerative disorders and Paget’s disease of bone that are in part the result of an 
accumulation of aggregates of misfolded proteins (193). Moreover, proteostatsis-
imbalance has recently been described in the pathogenesis of lung disease. Min et al. 
(194) reported increased VCP expression correlated with severity of COPD and also 
found VCP expression was higher in lung tissue from smokers compared to non-smokers. 
In that study, VCP expression was also associated with NFκB and GADD (growth arrest 
and DNA damage inducible gene) activation in tissues isolated from COPD subjects and 
cigarette smoke-exposed mice. Nrf2 degradation was also reported with overexpression 
of VCP in vivo. Asai et al. (195) have specifically demonstrated that VCP mediates the 
degradation of IκBα, which is a critical inhibitor of NFκB. Finally, in a murine model of 
acute lung injury induced by lipopolysaccharide, inhibition of VCP with salubrinal 
diminished NFκB-mediated IL-6 production and inflammation (196). Taken together 
(Figure 5.10), the present study and previously published investigations suggest 
plausibility of Vcp as an important gene candidate for further study in neonatal hyperoxic 
lung injury.  
 Trim30 is another interesting cis-eQTL genes identified in our analysis. Tripartite-
motif 30 belongs to family of proteins that has recently been found to have a role in 
regulating innate immunity. Shi et al. (197) demonstrated in vitro that Trim30 negatively 
regulates TLR-mediated NFκB activation by targeting activators (TAB1 and TAB2) of 
IκB kinase for degradation and inhibing Traf6 auto-ubiquitination. Furthermore, mice 
overexpressing Trim30 were more resistant to endotoxic shock. Subsequent studies of 
Trim30 revealed that it can inhibit ROS-mediated NRLP3 inflammasome activation and 
that inhibition of Trim30 leads to increased caspase 1 activation and IL1β expression 
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(198). Consequently, Trim30 exhibits biological plausibility for a role in neonatal 
hyperoxic lung injury and may contributed to differential susceptibility.  
 Interestingly, cystic fibrosis transmembrane conductance (Cftr) was identified by 
eQTL analysis with baseline gene expression and hyperoxia-induced differential gene 
expression in the lung. Mutations in Cftr are the primary cause of cystic fibrosis in 
humans; however, mutations in Cftr or targeted deletion of Cftr in mice does not produce 
similar disease (199). A large body of evidence suggests a link between Cftr and airway 
inflammation (200-202). Yet this is a case where the biology of the mouse differs from 
that of the human, and it is important to note that this is always a limitation of using 
animal models of human disease.   
 It is also important to note that the results of expression analyses do not confirm 
mechanisms, but provide candidate genes and gene networks to test for relevance in the 
model. Validation of associated SNPs with expression levels as well as gene expression 
and phenotypes must be performed. However, a number of testable hypotheses have been 
described that suggest further consideration. The results of this integrated and genetic and 
genomics approach were internally consistent and also coincided with previously 
published studies, and supports the potential importance in disease pathogenesis.  
 Results presented in Chapters 4 and 5 have shown NFκB and MAPK pathways to 
be centrally involved in hyperoxic lung injury in neonatal mice. Furthermore, there is 
substantial evidence in the literature that these pathways contribute to lung injury, 
including BPD (178, 203-205). An attractive therapeutic target would have a role in 
regulating both of these pathways that perturb normal cell growth and development and 
promote inflammation.  
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Figure 5. 1 Relatedness of inbred strains of mice. Inbred mice are divided into 7 
groups based on evolutionary relationships. Group 1: Bagg albino derivatives; Group 2: 
Swiss mice; Group 3: Japanese and New Zealand mice; Group 4: C57 and C58 strains; 
Group 5: Castle’s mice; Group 6: Little’s DBA and related strains; Group 7: wild-derived 
strains. Strains underlined in blue were used for genomic analysis of hyperoxic lung 
injury in neonatal mice. Adapted from Petkov et al. Genome Research 14 (2004). 
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Figure 5. 2 Profiles of hyperoxia-induced differential gene expression. Gene 
expression profiles in 30 strains of inbred mice are shown for transcripts that having a 
fold change greater than 1.5 in at least two strains of mice following 72 hours of 
hyperoxia exposure. Transcript levels are shown as quantile normalized and Log2 
transformed mean intensities (n=3/strain)  
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Figure 5. 3 Baseline and hyperoxia-induced gene expression. The venn diagram 
demonstrates the overlap in genes differentially expressed in lungs from 30s strains of 
mice at postnatal day 4 and after 72 hours hyperoxic exposure. 
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Figure 5. 4 Genome-wide cis-eQTL analysis. A. All significant haplotype-transcript 
associations are shown by global location. Cis-regulated eQTL genes are located at the 
diagonal line and all other associations are trans-regulated genes. P < 0.05 B. The 
Manhattan plot for Trim30 is shown to demonstrate the significant cis-acting SNP on 
chromosome 7 with a –Log10P value of 10.0.  
A.  
 
B.  
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Figure 5. 5 IPA network of cell death, antigen presentation, cellular movement, 
carbohydrate metabolism, and protein folding. This network of genes represents direct 
and indirect relationships between genes identified in QTL, eQTL, and correlation 
analysis with hyperoxic lung injury phenotypes. The top two networks in Table 5.6, both 
having scores of 43, were merged and new relationships are represented in orange.  
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Figure 5. 6 IPA network of post-translational modification, protein folding, 
infectious disease, cell death, and cellular development and morphology. This 
network of genes represents direct and indirect relationships between genes identified in 
QTL, eQTL, and correlation analysis with hyperoxic lung injury phenotypes. The third 
and fourth networks in Table 5.6, having scores of 41 and 34, were merged and new 
relationships are represented in orange.  
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Figure 5. 7 KEGG pathway of apoptosis. Genes identified by QTL, eQTL, and 
correlation analysis with hyperoxic lung injury phenotypes are involved in the apoptotic 
pathway and are highlighted in red. Casp9, highlighted in blue, was both correlated to 
hyperoxia-induced neutrohpilia and identified as a cis-eQTL.  
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Figure 5. 8 KEGG pathway of toll-like receptor signaling. Genes identified by QTL, 
eQTL, and correlation analysis with hyperoxic lung injury phenotypes are involved in 
toll-like receptor signaling and are highlighted in red.  
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Figure 5. 9 KEGG MAPK signaling pathway. Genes identified by QTL, eQTL, and 
correlation analysis with hyperoxic lung injury phenotypes are involved in mitogen-
activated protein kinase (MAPK) signaling and are highlighted in red. 
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Figure 5. 10 Interaction of NFκB and MAPK signaling with valosin-containing 
protein. Valosin-containing protein (VCP) was identified as a cis-eQTL in hyperoxic 
lung injury. Relationships between VCP, NFκB, and MAPK pathways are illustrated with 
IPA.  
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Table 5.1 Variation in hyperoxia-induced gene expression in 30 strains of mice. Fold 
change ranges are shown for genes that were differentially expressed in lungs in at least 
two strains following 72 hours hyperoxia exposure. The number of genes in each range is 
given. Fold change is based on Log2 transformed probe intensities.  
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Table 5.2 Differentially expressed genes in the lung after 72 hours exposure to 
hyperoxia. Transcripts and respective genes having a fold change greater than 5.5 are 
shown with the corresponding Entrez gene ID, accession number, and chromosome.  
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Table 5.3 DAVID classification of hyperoxia-induced differential gene expression. 
Gene ontology categories and KEGG pathways and the associated number of genes are 
listed for transcripts differentially expressed in neonatal lungs after 72 hours hyperoxia 
exposure.  
 
 
 
 
 
 
 
 
 
 
Gene Ontology # Genes
Cellular process 705
Metabolic process 524
Cellular component organization 144
Developmental process 196
Establishment of localization 166
Death 42
Localization 184
KEGG Pathways # Genes
Purine and pyrimidine metabolism 34
Chemokine signaling pathway 22
Lysosome 16
Ribosome 13
Leukocyte transendothelial migration 15
Cell adhesion molecules 18
T cell receptor pathway 11
Adherens junctions 10
Toll-like receptor signaling pathway 12
HYPEROXIA-INDUCED DIFFERENTIAL GENE EXPRESSION
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Table 5.4 Genome-wide cis-eQTLs in hyperoxia exposed neonatal lungs. Genomic 
loci (SNPs) that significantly associate with expression of a transcript probe within 1Mb 
were identified as cis-eQTLs. Analysis was done using lungs from 30 strains of inbred 
mice exposed to 72 hours hyperoxia after birth.  
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Table 5.5 Correlation of hyperoxia-induced gene expression and PMN influx in 30 
strains of inbred mice. A linear regression model was used to determine the correlation 
(r) and unadjusted P-value between hyperoxia-induced transcript probe intensities and 
BALF PMN counts obtained after 72 hours hyperoxia exposure.  
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Table 5.6 IPA networks and physiological functions associated with variation in 
hyperoxia-induced gene expression. Ingenuity pathway analysis was used to 
characterize the associated networks and physiological functions in genes identified in 
QTL, cis-eQTL, and correlation analysis in gene expression in the lung and lung injury 
phenotypes following 72 hours hyperoxia exposure. 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6 
 
DISCUSSION 
 
The objective of this dissertation was to utilize an integrated genetics and 
genomics approach to identify predictors of susceptibility to BPD in preterm infants 
using a neonatal murine model of hyperoxic lung injury. While differential susceptibility 
has been described in clinical studies of BPD, genetic determinants driving this 
susceptibility are poorly understood. It was hypothesized that the results of this genetical 
genomics methodology would coincide with mechanisms of injury that have previously 
been described as well as provide insight into mechanisms and genetic determinants of 
injury not previously considered. 
 
A genetic model of neonatal hyperoxic lung injury in mice 
BPD is an inconsistent disease with pathologies that are not fully understood. 
Numerous studies have aimed to identify predictors or biomarkers of BPD development 
and severity. Markers of neutrophilia (lactoferrin and myeloperoxidase activity), 
macrophage activation (interleukin-8 and interleukin-1β), and epithelial damage vary in 
clinical BPD as well as markers of oxidative stress (protein oxidation products and 
malondialdehyde) (6, 35, 94, 98, 100, 206, 207). To date, there is not an animal model 
that resembles this variation, which is due in part to variation in environmental factors 
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(treatment), but also due to genetics, as indicated by heritability estimates 
reported in clinical studies (82). An important strength to animal models of disease is the 
control over exogenous factors, which in the case of models of BPD and neonatal 
hyperoxic lung injury, includes amount and duration of supplemental oxygen and/or 
ventilation parameters.  
 The strengths of our model of neonatal hypoxic lung injury in inbred mice extend 
beyond this as it accounts for the role of genetic variation in response to postnatal 
hyperoxia. Response phenotypes were similar to those reported in clinical studies as 
inflammation and epithelial cell injury were observed, and moreover, these response 
phenotypes varied across strains with little correlation. This demonstrates that genetic 
factors contribute to the timing, mechanism, and extent of injury, and heritability 
estimates support this observation.  
Importantly, this animal model is also age-appropriate. Studies of hyperoxic lung 
injury in adult mice have described mechanisms of injury and have highlighted the role of 
genetics in susceptibility; however, strains that exhibited marked injury or sensitivity to 
hyperoxic lung injury (BALB/cJ and 129S1/SvImJ) were resistant as neonates and strains 
resistant as adults (C3H/HeJ) were susceptible to hyperoxic lung injury in the postnatal 
period (88, 89, 105). This is not entirely surprising as neonatal lungs are deficient in 
antioxidant and immune capacities and continue developmental processes after birth (77, 
208). Interestingly, similar age-specific response and injury have been described in 
respiratory syncytial virus, particulate matter exposure, and cigarette smoke exposure 
(107-109). Taking all of these details into consideration, our model of neonatal hyperoxic 
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lung injury resembles response phenotypes and variation of clinical BPD and is age 
appropriate (i.e. not a recapitulation of previously published studies).  
 
Haplotype association mapping identifies Chrm2 as a candidate susceptibility gene 
Developing this model was necessary to address the objective of this dissertation 
and was employed, first, for genetic analysis of hyperoxic lung injury phenotypes. 
Haplotype association mapping is similar to genome-wide association studies done in 
clinical cohorts, and queries for associations between haplotype (single nucleotide 
polymorphisms) and quantitative disease phenotypes. Genomic loci that associate with 
phenotypes are termed quantitative trait loci (QTLs) and are subsequently studied for 
underlying genes that may contribute to variation in disease. Using this approach, we 
identified significant QTLs for BALF macrophages and polymorphonuclear leukocytes 
on chromosomes 1, 2, 4, 6, 7, and 9. To prioritize genes found within these QTLs, we 
identified genes have non-synonymous coding SNPs as these may have the most obvious 
impact on disease phenotypes because they cause an  amino acid change in the encoded 
protein, which can significantly alter protein function and stability (128). These genes 
included Cntnap5b, Cyp2j11, Cyp2j5, Cyp2j9, Cyp2j6, Mgmt, and Chrm2, the latter 3 of 
which were of particular interest due to biological plausibility.  
Chrm2 was selected for further functional validation in neonatal hyperoxic lung 
injury after consideration of a SNP (rs30378838, C/T) resulting in a substitution of a 
proline residue at position 265 with leucine. Chrm2 encodes the M2 muscarinic 
acetylcholine receptor, a member of the muscarinic receptor family (M1-M5), which 
belong to a superfamily of G protein-coupled receptors. The polymorphism is found in 
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the third intracellular loop of the encoded membrane receptor, which is important for 
specificity of receptor activity. Modulation of this loop was hypothesized to affect 
receptor function in hyperoxic lung injury, and interestingly, targeted deletion of Chrm2 
significantly reduced hyperoxia-induced edema and injury in the lung.  
The role of the M2 muscarinic receptor in neonatal hyperoxic lung injury is not 
immediately obvious. Cholinergic receptors have been well characterized in airway 
reactivity and asthma pathogenesis (209); however, modulation of immune mechanisms 
involving the cholinergic system have recently been described in the context of 
neuroimmune cross-talk and the non-neuronal cholinergic system.  
The communication between the nervous and immune systems is complex and 
highly dynamic, involving both the peripheral and central nervous system in 
inflammatory pathways. Neuroimmune dialogue has been described at length in a number 
of reviews, including examples in disease such as rheumatoid arthritis and sepsis, and 
more recently, airway inflammation (210-212). The “cholinergic inflammatory reflex” is 
of particular interest and involves the vagus nerve. Briefly, the vagus nerve contains 
sensory nerves that innervate the airway epithelium to detect and regulate biological 
processes and functions. A diverse range of stimuli can act on the vagus nerve (i.e. 
response to hyperoxia), causing release of acetylcholine (ACh) from vagal 
parasympathetic nerves, which can then bind to muscarinic and nicotinic receptors on 
target cells, including immune cells, bronchial and airway epithelium, and smooth 
muscle. More specifically, evidence suggests the M2 receptor is limited to expression on 
macrophages, T cells, epithelial cells, smooth muscle cells, and parasympathetic nerves. 
M2 receptors on parasympathetic nerves function in a negative feedback loop, where 
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binding of ACh to the M2 receptor inhibits further ACh release. There is strong evidence 
that implicates the “cholinergic inflammatory reflex” mediated by ACh, is anti-
inflammatory and attenuates the release of cytokines including Tnf-α, IL-1β, IL-6 and IL-
18. So, presumably, deletion of Chrm2 could lead to increased ACh release from 
parasympathetic nerves, and protect against hyperoxia-induced inflammation by 
inhibiting release of cytokines from ACh-responsive inflammatory cells.  
 The non-neuronal cholinergic system may also be responsible for the observed 
response to hyperoxia in Chrm2+/+ and Chrm2-/- neonates. The “cholinergic inflammatory 
response” is not the only source of ACh as choline acetyltransferase a ubiquitously 
expressed enzyme. Epithelial cells (ciliated and non-ciliated), smooth muscle cells, 
endothelial cells, and immune cells (lymphocytes, macrophages, and granulocytes) all 
synthesize ACh; however, unlike neuronal cells, it is quickly degraded (139, 213). 
Functions of ACh in the non-neuronal system that could contribute to hyperoxic lung 
injury include enhanced cell proliferation and immune function(214). Less is known 
regarding muscarinic receptor subtypes on various immune cells and associated immune 
responses, but it has been demonstrated that stimulation of alveolar macrophages and 
bronchial epithelial cells with ACh increases production of chemotactic factors (214). 
Interestingly, ACh has also been linked to reduced Tnf and IL-1β release, thromboxane 
production, and costimulatory molecule synthesis, which are all anti-inflammatory (215). 
As M2 receptor function is predominantly inactivating, then these latter, anti-
inflammatory effects may be adversely affected by deletion of Chrm2, contributing to 
inflammation.  
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 Identification of the precise mechanism by which the M2 receptor is functioning 
in the neonatal lung in response to hyperoxia may be challenging as there is not a specific 
agonist or antagonist of the M2 receptor subtype. However, from a translation 
perspective, the mechanism of action is not as important as reducing lung injury induced 
by oxidant stress. That is to say, pharmacological inhibition of muscarinic receptors (i.e. 
atropine) should be evaluated in neonatal hyperoxic lung injury. Antagonists of 
muscarinic receptors are widely available and would provide great therapeutic potential if 
they were found to reduce oxidant injury in neonatal lungs. However, since muscarinic 
receptors can have opposing roles, if a pan-muscarinic receptor antagonist did not reduce 
hyperoxic lung injury, ascertaining the mechanism of M2 receptor protection would be 
important.  
 
eQTL analysis and the association of Vcp with neonatal hyperoxic lung injury 
 eQTL analysis was performed to identify SNPs that associated with transcript 
expression levels in postnatal lungs (baseline) and hyperoxia-exposed postnatal lungs. 
Understanding how genetic variation contributes to genomic variation at baseline can 
provide information about postnatal lung growth and development and may provide clues 
regarding predisposition to injury to the lung. The same question can be asked following 
a challenge, in this case hyperoxia exposure, to elucidate how genetic variation 
contributes to genomic response. The eQTL analysis described in Chapters 4 and 5 
addressed cis-eQTLs, or associations between transcript expression and a locally inferred 
haplotype (SNP).  
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 Adam17 and Eif2ak2 were the genes with cis-eQTLs in postnatal lungs that have 
biological plausibility in the model. Adam17 is a disintegrin and metalloproteinase that 
regulates acute lung inflammation through proteolysis (shedding of tight junction 
molecules) of the endothelial membrane, enhanced release of inflammatory mediators 
(IL-6), and leukocyte recruitment (176). In addition to this details more thoroughly 
described in Chapter 4, Adam17 expression levels after hyperoxia exposure, but not at 
baseline, correlated with hyperoxia-induced neutrophilia. An eQTL in the postnatal lung 
was also characterized in Eif2ak2, or eukaryotic initiation factor kinase-2, induced by 
hyperoxia exposure and described in the stress response in the newborn rat lung (179). 
This gene, in particular, is of further interest for trans-eQTL analysis that identifies 
associations between transcript expression levels and non-local genomic loci. Trans-
eQTL analysis is a powerful tool to identify genetic variation in regulatory elements that 
modulate expression of a group of genes that may or may not be described by an 
ontological function. As a translation initiation factor, genomic variation of Eif2ak2 could 
potentially impact a number of genes that may be important in hyperoxia response in the 
postnatal lung. Further investigation of Adam17 and Eif2ak2, and trans-band analysis will 
yield important information regarding genetic predisposition of the neonatal lung to 
injurious inflammation. 
 Cis-eQTL analysis in postnatal lungs exposed to hyperoxia also implicated a 
novel and important gene for future study: Vcp. Valosin containing protein 
(VCP/p97/Cdc48) is an important mediator of protein homeostasis, or proteostasis, which 
includes protein synthesis, folding, trafficking, disaggregation, and degradation. The 
ubiquitin proteasome system is one component of proteostasis that requires VCP activity 
138 
 
and regulates signaling pathways, cell cycle progression, and the stress response (196). 
Dysfunction in proteasome activity leads to altered immune function and promotes 
inflammation through increased NFκB transcription, decreased Nrf2 transcription, and 
GADD activation (194). Interestingly, cigarette smoke exposure caused an increase in 
VCP expression, though a role of VCP has not been previously demonstrated in 
hyperoxia exposure (194). To determine if VCP is involved in neonatal hyperoxic lung 
injury, expression could be compared in lung tissue from neonatal mice exposed to 
hyperoxia. Salubrinal has also been shown to diminish the pro-inflammatory response 
both in vitro and in vivo by inhibiting elongation initiation factor 2 alpha (Eif2α), which 
is downstream of Vcp activity. Eif2α is also downstream of Eif2ak2 (and Eif2ak1, 
Eif2ak3, and Eif2ak4) (216), thus, salubrinal may impede hyperoxia-induced 
inflammation and injury based on these implications from cis-eQTL analysis, and 
validation of this implication in animal models and clinical cohorts is necessary. 
 
Genomics of postnatal lung development and injury 
 Identification of overlapping and related disease associated genes through 
multiple genetic and genomic approaches as described above, in a limited sense, is a 
recent trend in bioinformatic disease prediction (217). Ingenuity pathway analysis (IPA) 
and the database for annotation, visualization, and integrated discovery (DAVID) were 
used to assess the overlap or relatedness of genes identified by QTL, eQTL, and genomic 
phenotype correlation analysis. Genes and gene products identified by this integrated 
approach associated with TGFβ, NFκB, and MAPK signaling, which coincides with 
previously published studies on neonatal hyperoxic lung injury and lung development. 
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Moving beyond these conclusions with only this information would make candidate gene 
identification an arduous and lengthy task so future directions must include additional 
means for prioritization. Furthermore, genetic and genomic variation that underlie 
susceptibility to neonatal hyperoxic lung injury will involve a number of genes given the 
complexity of disease phenotypes. It is likely that multiple genes contribute to each 
phenotype and that genes may or may not contribute to more than one phenotype (217). 
Additional bioinformatics tools are available to classify integrated genetic and genomic 
data including Prioritizer and Endeavour, and these could be employed to validate the 
implications from IPA and DAVID analysis. 
 Another method that can be applied to the vast amount of genomic data regarding 
neonatal lung development and oxidant injury is multi-gene modeling. Regression 
modeling or cluster analysis of gene expression profiles using phenotypic data from a 
select number of inbred strains can create a training set of data (218). Bioinformatic and 
statistical methods can then be employed to determine which set of genes best associates 
with the phenotype of interest. Further validation of this hypothetical predictive model 
would then include a test set of inbred mice where genomic analysis was used a priori to 
predict the phenotypic response. There is immense potential of this approach after 
validation in human neonatal lung disease, as custom array-based technologies could 
easily be developed to predict response to oxidant injury on an individual basis.  
 Thus far, the focus of this dissertation research and discussion has been 
mechanisms of oxidant injury in neonatal lungs as a means to ascertain novel therapeutic 
strategies, but another approach is thought-provoking. A common feature of BPD and 
neonatal hyperoxic lung injury is disruption of lung development during saccularization, 
140 
 
and consequently, impaired alveolarization. But what if factors contributing to or 
promoting alveolarization could be identified and then applied therapeutically to 
circumvent disruption of airway maturation? Early lung morphogenesis has been 
characterized and elegant studies involving embryonic lung explants demonstrate the 
necessity and sufficiency of various transcription factors (Fgf10, Ttf-1, Foxa2) in 
inducing branching morphogenesis (188, 219). Similarly Ttf-1, NF-1β, and GATA-6 are 
important in cell-specific differentiation in the cannalicular phase (219).  
Factors involved in early lung development are the most well characterized, and 
as lung development proceeds, less is understood such that the “switch” regulating 
transition to alveolarization is unknown. Numerous studies have investigated gene 
expression profiles in fetal and postnatal lung development in an effort to better describe 
saccularization and alveolarization. Transcription factors, nuclear receptors, growth 
factors, and transcriptional coactivators are all necessary for normal lung development 
(188). For example, mice lacking glucocorticoid receptors, platelet derived growth factor 
(PDGF), vascular endothelial growth factor (VEGF), calcineurin b1, GATA-6, Taz, or 
NF-1 all have maturational defects in saccular-alveolar development leading, in most 
cases, to lethality (219-221). Genomic studies have more recently been conducted to 
identify saccularization and alveolarization specific genes. Bonner et al. (162) studied 
gene expression patterns through embryonic and fetal lung development to identify gene 
signatures unique to each stage of development that may be regulated by critical 
transcription factors, such as Ttf-1 and Hnf-3β. They developed a gene set linked to 
postnatal maturation which included a number of genes identified in our analysis (Ctgf, 
Gadd45b, Gstm2, and Casp9).  Boucherat et al. (222) queried a similar question; 
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however, they identified gene expression profiles specific to lung fibroblasts to identify 
factors regulating alveolar septation. Among the list of genes that were upregulated 
during secondary septation were Hoxa5, Hoxa2, Hoxa4, RXRγ, Wnt5a, Ndp, and Fzd1. 
All had diminished expression levels when neonatal rats were exposed to hyperoxia, and 
expression of Ndp and Fzd1 never recovered.  
These briefly described studies and those not discussed here have yet to solve the 
alveolarization “switch”, but work is ongoing, and as genes are further elucidated, the 
genetical genomic data compiled in our study will be invaluable to better understand 
variation in hyperoxia-impaired lung development. This is important from a clinical 
perspective because there is a potential to deliver or administer “alveolarization factors” 
exogenously to encourage postnatal lung growth. This methodology has been practiced in 
animal models, as neonatal rats exposed to hyperoxia had improved lung development 
when treated with recombinant human VEGF compared to controls (223). More 
specifically, as alveolarization genes are validated, we can determine those that are 
modulated by oxidant stress and in which strains. Subsequently, those strains could be 
screened in a chronic hyperoxic lung injury model that would impair alveolarization, and 
supplementation of the alveolarization genes could be tested for improved lung 
development.  
The objective of this dissertation was to integrate genetic and genomic approaches 
to identify predictors of susceptibility to and mechanisms of injury in neonatal hyperoxic 
lung injury in inbred mice that would provide insight to oxidant injury in preterm infants 
developing BPD. Our model employed haplotype association mapping with hyperoxic 
lung injury phenotypes and genomic profiling to identify QTLs, eQTLs, and gene 
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expression correlated with disease. Chrm2 was identified as a candidate susceptibility 
gene and in vivo validation warrants future investigation of this gene in a clinical cohort. 
Other candidate genes include Mgmt, Cyp2j6, Vcp, Eif2ak2, and Adam17 and additional 
studies are needed to determine a functional role of these genes in susceptibility to 
neonatal hyperoxic lung injury. Furthermore, integrated analysis of genes identified 
through multiple approaches suggests that variation in inflammation and stress response 
mechanisms contribute to disease predisposition. BPD remains the most common 
morbidity facing preterm and low birth weight infants and it is impossible to know which 
infants will develop BPD and to what extent.  The disease model and genetic 
determinants described herein provide great potential for improving the understanding of 
oxidant injury in preterm infants and susceptibility, which is critical to reducing the 
burden that is BPD. 
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